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1. Introduction: 
 
Systemic arterial hypertension, or simply called hypertension, is a major medical and 
public health problem worldwide as it is an important risk factor for coronary heart 
disease, heart failure, cerebrovascular disease and renal failure. The past century has 
seen hypertension grow to epidemic proportions across the world. 
What is worrying, is that hypertension is usually asymptomatic resulting in some 
calling it the “the silent killer”. Patients may be asymptomatic not only to 
hypertension, but also to the organ damage caused by it. Cardiovascular disease risk 
increases as the blood pressure increases starting at a blood pressure of 115/75 mm 
Hg. 
Traditionally, hypertension is a disease that has been associated with older age groups. 
Over time, the profile of hypertension has changed. Population studies have shown an 
increasing prevalence across populations. The prevalence among younger individuals 
in also increasing,  
This study aims to study the profile of younger patients (18 – 40) years with 
hypertension, as they comprise a population of “young hypertensive” patients. Though 
there is no set definition of “young hypertension”, individuals younger than 40 years 
of age have traditionally been considered to have young onset hypertension and 
evaluated for secondary causes of hypertension.  
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By studying this younger age group of hypertensive patients, the study aims to 
determine the prevalence of secondary hypertension and describe the risk factors of 
primary hypertension in this population.  
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2.1 Objectives 
To study and profile patients with young onset hypertension who present to the General 
Medicine department of CMC, Vellore during a period of 1 year. 
 
 
 
 
 
2.2 Aims 
1. To determine the prevalence of secondary hypertension among young hypertensives     
presenting to the Department of General Medicine. 
2. To identify the modifiable risk factors for Essential hypertension in young hypertensive 
patients.  
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3 Review of literature 
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3.1 Hypertension – Definition 
  
The Joint National Committee VII defined hypertension in adults aged 18 and older as 
follows. The blood pressure reading is taken as an average of two or more properly 
measured readings taken with the patient seated on each of two or more office visits. 
 
 
 
Blood pressure 
classification 
Systolic BP  (mm Hg) Diastolic BP  (mm Hg) 
Normal < 120 <80 
Prehypertension 121 – 139 80 – 89 
Stage I hypertension 140 – 159 90 – 99 
Stage II hypertension ≥ 160 ≥ 100 
 
 
 
 
 
 
 
 
 
 
 
8 
 
3.2 The global burden of hypertension: 
 
Times change and with it the spectrum of diseases affecting the human race. Non 
communicable diseases have overtaken communicable diseases as the leading cause of 
death worldwide. With Industrialisation and Globalisation, the burden of non- 
communicable diseases has extended to the developing world.  
Non communicable diseases account for approximately 60% of death worldwide with 
cardiovascular diseases accounting for 30%. In 2008, it was estimated that 4 out of 5 
deaths in countries of low- and middle- income, were due to non- communicable 
diseases. The effect of these diseases is felt across ages with 1 in 4 deaths due to non- 
communicable diseases occurring in those below the age of 60 (1) 
Across the world, cardiovascular diseases account for close to 17 million deaths a 
year, which is nearly a third of all deaths. Of these, complications secondary to 
hypertension accounts for 9.4 million deaths worldwide. Hypertension is responsible 
for 45% of deaths due to ischemic heart disease and 51% of deaths due to stroke (2) 
The burden of DALYs (Disability Adjusted Life Years) due to non-communicable 
diseases is 48% worldwide.  In 2010, the global cost of cardiovascular disease was 
estimated at US 836 billion (the average per capita cost being US$ 125) with an 
estimate that by 2030, this would rise to US$1,044 billion. Thus this estimate predicts 
a 22% increase in the financial burden of cardiovascular disease.(1) 
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3.3 The Indian scenario: 
 
Hypertension is a leading cause of Morbidity and mortality in India. A study done in 
1997, looking at the global burden of disease, reported that in 1990 in India, there 
were a total of 9.4 million deaths, with cardiovascular diseases accounting for 2.3 
million. Deaths due to coronary heart disease were 1.2 million and another 0.5 million 
deaths were due to stroke (3). 
Based on this data and the trends of these diseases, it was predicted that by 2020, there 
would be an increase in cardiovascular deaths in India by 111%. This increase is far 
greater than that predicted for countries like China (77%), other Asian countries 
(106%) and the economically developed countries (15%) (4). 
57% of all stroke deaths and 24% of all coronary heart disease deaths in India are 
secondary to hypertension. Hypertension is a controllable disease and so its 
management is of utmost importance if the mortality due to it is to be reduced. 
Epidemiological studies looking at the prevalence of hypertension in India, have 
shown a high prevalence in various parts of the country with rates almost similar to 
that of a developed country like the United States of America. 
Studies done in the 1950s, looking at urban populations in India, had taken a systolic 
blood pressure cut off of 160 mm Hg and a diastolic blood pressure cut off of 95 mm 
Hg and had reported the prevalence of hypertension to be 1.2 – 4.0%. 
From 1960 to 2000, there were many studies done which looked at the prevalence of 
hypertension in various parts of India and the reported prevalence were – 4.35% in 
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Agra, 6.43% in Rohtak, 15.52% in Bombay, 14.08% in Ludhiana, 10.99% in Jaipur, 
11.59% in Delhi and 13.1% in Chandigarh (4). 
Subsequent studies have shown a much higher prevalence of hypertension with the 
prevalence in Jaipur reported at 30% in men and 33% in women, in Mumbai at 44% in 
men and 45% in women (4) and in Trivandrum at 31% in men and 41% in women (5) 
and in Chennai at 14% (6).  
Yadav et al, have reported the age and sex matched prevalence of hypertension in an 
urban population of Lucknow to be 32.2%. They also found the prevalence of 
prehypertension in this same population to be 32.3%. While the prevalence of 
hypertension was highest in the age group of 60 – 69, the prevalence of 
prehypertension was highest in the age group of 30-39.  
A higher proportion of hypertensives (66%)  and pre-hypertensives (56%) had two or 
more cardiovascular risk factors as compared to normotensive subjects (39%) (7) 
Das et al, studied the prevalence of hypertension in an urban population in West 
Bengal, and found it to be 24.9%. They also noted that 58.7% of the study subjects 
had prehypertension (8). 
Studies looking at the prevalence of hypertension in rural populations have recorded 
alarmingly high rates of hypertension prevalence. 
In a study from rural Davangiri, Karnataka, the prevalence of hypertension was found 
to be 19.1% in men and 17.5% in women (9). In a population in rural Haryana, the 
prevalence of hypertension, in a population whose ages ranged between 16 to 70,  was 
reported at 3.5% in men and 5.8% in women (10). 
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3.4 Hypertension and its risk factors: 
 
Hypertension, can be broadly divided into two groups – the first being Primary 
hypertension or Essential hypertension and the second being Secondary hypertension. 
The difference between the two is that in Secondary hypertension, the hypertension is 
due to an underlying disease (example: chronic kidney disease or Pheochromocytoma) 
while in Essential hypertension, there is no underlying cause. 
Essential hypertension occurs due to the interaction between genetic and 
environmental factors.  
i) Primary hypertension: 
 
 Different prevalence rates in different populations can be attributed to the different 
environmental factors like smoking, alcohol use, excess dietary sodium and fat, low 
potassium and fibre intake, physical inactivity and psychosocial stress.  These 
environmental factors are modifiable and it is important to understand them as part of 
the management of hypertension involves addressing the modifiable risk factors.  
The non-modifiable risk factors are age, gender, ethnic background and 
socioeconomic status. Epidemiological evidence has shown that in India, changing 
population demographics has resulted in increased risk factors for hypertension. 
Contributing to these factors are Urbanisation and development, increasing life 
expectancy and affluence.  Changing dietary practices, increasing sedentary lifestyles 
and increasing stress have all contributed to the epidemic of hypertension. 
The following is an elaboration on the various risk factors of hypertension. 
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ii) Secondary hypertension: 
 
There are a number of common and uncommon diseases that cause a rise in blood 
pressure and may result in secondary hypertension. The underlying cause is in many 
instances is potentially correctable. These may be present with the risk factors for 
Primary hypertension, making the control of blood pressure difficult. Patients who 
should be suspected to have a secondary cause for the hypertension are those who 
have resistant hypertension or who develop hypertension at extremes of age. 
A secondary cause should also rule out in those presenting with symptoms of a 
secondary cause or with abnormal laboratory tests (example: hypokalaemia in primary 
aldosteronism, or elevated creatinine in chronic kidney disease). 
 
The following are some of the causes of secondary hypertension: 
Renal Parenchymal diseases 
Renal tumors 
Obstructive uropathy 
Renovascular Arteriosclerotic 
Fibromuscular dysplasia 
Adrenal Primay aldosteronism 
Cushing’s syndrome 
17 α hydroxylase deficiency 
11 β hydroxylase deficiency 
11-hydroxysteroid dehydrogenase deficiency 
Pheochromocytoma 
Aortic coarctation  
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The etiological cause for the secondary hypertension varies with age groups. In 
children, an identifiable secondary cause is present in up to 85%, with the commonest 
being renal dysfunction. In middle aged adults, this decreased to 5-10% with the 
commonest cause being primary hyperaldosteronism.  
Obstructive sleep 
apnoea 
 
Preeclampsia/eclampsia  
Neurogenic Psychogenic 
Diencephalic syndrome 
Familial dysautonomia 
Polyneuritis (acute porphyria, lead poisoning) 
Acute increased intracranial pressure 
Acute spinal cord section 
Miscellaneous 
endocrine 
Hypothyroidism 
Hyperthyroidism 
Hypercalcemia 
Acromegaly 
Medications  High-dose estrogens 
Adrenal steroids 
Decongestants 
Appetite suppressants 
Cyclosporine 
Tricyclic antidepressants 
Monoamine oxidase inhibitors 
Erythropoietin 
Nonsteroidal anti-inflammatory agents 
Cocaine 
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A study prospective conducted in Sweden, among 7455 men aged 47 to 54 found the 
prevalence of secondary hypertension to be 11%. The commonest cause being renal 
parenchymal disease (11).  
A retrospective study, also conducted in Sweden, among 1000 women, found the 
prevalence of secondary causes of hypertension to be 5% with the commonest cause 
being renal parenchymal disease, followed by endocrine causes and renovascular 
disease. In 23% of these patients, their blood pressure normalised following treatment 
of the underlying disease (12). 
Studies from multi-speciality clinics and blood pressure clinics have reported a 
prevalence of secondary hypertension between and 8 to 10 % (13,14). 
A prospective study from Japan, evaluated 1020 patients for secondary causes of 
hypertension. Subjects with renal parenchymal disease were excluded. A two tiered 
evaluation for endocrine causes was done. They found the prevalence of secondary 
causes to be 9.1%, with the commonest cause among this being primary aldosteronism 
(6%).  Previous studies evaluating the causes of secondary hypertension had reported 
the prevalence of primary aldosteronism to be much less, mainly because specific 
evaluation for the same was not done (15). 
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iii) Age and hypertension: 
 
Blood pressure progressively increases with increasing age, and this phenomenon 
though a common one, is not universal. Hypertension that is age- related is 
predominantly systolic. It has been noted that systolic blood pressure rises into the 8th 
and 9th decades while the diastolic blood pressure remains constant or declines after 
50 years of age (16). 
In individuals over the age of 50, the systolic blood pressure is a better predictor of  
risk and in those below 50, it is the diastolic blood pressure that is a better predictor of 
mortality (17,18). 
Studies from around the world and India, have shown an increasing prevalence of 
hypertension with increasing age. The third NHANES study showed that the 
prevalence of hypertension increased with increasing age. The prevalence of 
hypertension was 7.3% in those aged 18 – 39, 32.4% in those aged 40 – 59, and 
65.0% in those aged 60 years.  
Studies from India, have shown similar results. A study in a Parsi community of 
Mumbai, found the prevalence of hypertension to be 56.3% in those 60 years or older 
and 64.2% in those 70 years or older (19). Hazarika et al recorded a prevalence of 
hypertension in a geriatric population of Assam to be 63.63% (20). In South India, a 
study from Kerala, found the prevalence of hypertension in the elderly to be 51.8% 
(21). Similarly, another study, reported a 65% prevalence of hypertension in an 
elderly population combining subjects from India and Bangladesh (22).  
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Epidemiological studies have been carried out in various parts of the country on 
younger individuals. A study on an apparently healthy Western Indian population 
found the prevalence of hypertension among those less than 40 years to be 11% (23). 
A study among from Karnataka, looking at the prevalence of hypertension in 991 
individuals between the ages of 20 and 40 found it to be nearly 8% (24).  
Thus, age is a non-modifiable risk factor for developing hypertension. 
iv) Gender and hypertension 
 
The relationship between gender and hypertension has been studies, with prevalence 
rates between the two sexes varying by world region. The absolute differences are 
small, with the greatest difference seen in the countries comprising Latin America and 
the Caribbean at 5.9%  (25). 
It has been seen that at younger ages, the prevalence of hypertension in men is more 
than that of women, and with increasing age, the prevalence in women seems to be 
more.  
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v) Family history and hypertension 
 
Hypertension has been known to run in families. This could be attributed to shared 
genetic and environmental factors.  
The Johns Hopkins precursor study found that subjects who had a positive parental 
history of hypertension had higher mean systolic and diastolic blood pressure levels in 
medical school. 
They also found that by the age of 40, the cumulative incidence of hypertension was 4 
times greater in those whose parents had hypertension than in those whose parents did 
not.  
The risk of developing hypertension was even greater in those whose parents had an 
early onset of hypertension.  Subjects whose mother and father had developed 
hypertension at the age of 55 or younger  had a 7.1 fold higher risk of developing 
hypertension during their adult life as compared to those without a hypertensive parent 
(26). 
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vi) Socioeconomic status and hypertension 
 
Socioeconomic status is a risk factor for cardiovascular disease. The relationship 
between the two is not direct but rather through a complex interplay between various 
factors like stress, exercise and diet. And because these factors are modifiable, it is 
important to understand this. Various models have been proposed to explain the 
relationship between socioeconomic status and hypertension. 
It has been postulated that socially disadvantaged people could face stressors from 
their job and neighbourhood which coupled with poor knowledge and strained 
finances could result in these individuals consuming food that is cheap and high in 
calories, saturated fats and salt, which in turn would result in obesity and 
hypertension. These in turn could result in chronic ill health, further limiting their job 
options and resulting in further stress (27). 
 
Lower socioeconomic status has been associated with higher mean blood pressures in 
studies from developed countries. This inverse relationship is stronger and more 
consistent in women than in men.  
It has been seen that subjects with lower socioeconomic status have a poorer 
biobehavioral profile with regards to the modifiable risk factors of body mass index, 
heart rate, waist circumference, alcohol consumption, smoking and exercise. 
The RECORD Cohort Study (Residential Environment and CORonary heart Disease) 
from France, studied the relationship between socioeconomic status and hypertension 
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among 5941 participants aged 30 – 79 years and found an inverse relationship 
between systolic blood pressure and decreasing individual education and decreasing 
residential neighbourhood education. The bulk of the associated between 
socioeconomic status and hypertension was mediated by body mass index/ waist 
circumference and resting heart rate (28). 
 
In the USA, the National longitudinal Study of Adolescent Health, a longitudinal 
study with more than 15,000 young adults found that higher household income and 
being married were both independently associated with a lower systolic blood 
pressure. They also found that the association between higher household income and a 
lower systolic blood pressure was by way of a lower resting heart rate (29).  
A study among 11,053 Israeli male military officers, found that systolic and diastolic 
blood pressures were highest among low ranking officers. Higher mean systolic blood 
pressures were also noted among office workers as compared to physical workers 
(30).  
Studies from India have shown varied results. A study looking at the association of 
socioeconomic status and hypertension in a rural South Indian population, found the 
prevalence of hypertension to be 22.5% in those belonging to the highest 
socioeconomic group and 8.8% in those belonging to the lowest socioeconomic group 
(31). 
In a study looking at rural tribal populations in India, it was noted that the prevalence 
of hypertension increased with increasing literacy and among land owners. 
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vii) Race and hypertension 
 
Prospective studies over time have shown a difference in hypertension between races. 
Among the various races, the prevalence and severity of hypertension tends to be 
more among the blacks. Factors that could contribute to this include environmental 
and genetic factors. The environmental factors that have been studied include high-
sodium/low-potassium diets and low socioeconomic status.  Genetic factors in blacks 
also play an important role predisposing them to left ventricular hypertrophy and 
hypertensive nephrosclerosis. Polymorphisms in the apolipoprotein L1 (APOL1) 
genes are more common in African-Americans than Europeans. This seems to put 
them at increased risk of end stage renal disease secondary to hypertensive 
nephrosclerosis and focal segmental glomerulosclerosis.    
Wang et al, in a prospective study compared ambulatory blood pressure between 
subjects of European-American descent and African-American descent over a period 
of 15 years, and found that those of African-American descent, had higher day time 
and night time systolic and diastolic ambulatory blood pressures. They also noted a 
decline in the blunting of nocturnal blood pressure among African-Americans by the 
age of ten which progressively worsened into adolescence (32). 
Studies from India have also shown a variation in the prevalence of hypertension and 
other cardiovascular disease risk factors among various ethnic groups within the 
country (33,34). 
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viii) Urbanisation and hypertension 
 
Epidemiological studies have shown the prevalence of hypertension to be higher in 
urban than in rural residences. The contributing factors this have been attributed to 
changes in the life style pattern, diet, physical activity and increased stress levels.  
The ICMR-INDIAB study, which looked at the prevalence of hypertension in urban 
and rural populations in three states and a union territory (Tamil Nadu, Jharkhand, 
Chandigarh and Maharashtra) found the prevalence of hypertension to be significantly 
higher among urban than rural populations. A study comparing rural and urban 
populations in Karnataka found the prevalence of hypertension among 991 individuals 
between the ages of 20 and 40 to be 8.79 % in the urban population and 7.30 % in the 
rural population (24).  
 
 
 
 
ix) Diabetes mellitus and hypertension 
Diabetes mellitus and hypertension are two diseases that are seen together, especially 
with increasing age.  Cardiovascular risk is significantly increased in diabetic 
individuals and in the presence of hypertension, this is increased even further. Thus, 
strokes, transient ischemic attacks and peripheral vascular disease are seen more 
frequently in diabetics with hypertension than in those without. Both diabetes and 
hypertension, independently cause accelerated atherosclerosis and ischemic heart 
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disease.  35 – 75% of the complications of diabetes mellitus have been attributed to 
hypertension.  
The prevalence of hypertension in diabetic individuals is twice that in non-diabetic 
individuals. This is especially so in Type I diabetics. Before the fifth decade, the 
prevalence of hypertension in diabetics is more in men than in women, subsequently 
the prevalence of hypertension appears to be more in women. The coexistence of 
diabetes mellitus with hypertension is more prevalent among blacks as compared to 
whites. The coexistence is also higher among those belonging to a lower 
socioeconomic status. The determinants associated with hypertension in diabetic have 
been attributed to age, gender, and race, longer duration of diabetes, obesity and 
persistent proteinuria. In Type I diabetics, it has been noted that hypertension develops 
following the onset of persistent proteinuria. Patients without diabetic nephropathy 
usually remain normotensive. In Type II diabetics, it has been found that about a third 
are hypertensive at the onset of diagnosis. Hypertension in diabetes results in 
acceleration of diabetic nephropathy and retinopathy. 
The pathology of hypertension in diabetics parallels that of hypertension that is age 
related and is characterised by increased vascular resistance. Premature ageing of the 
vascular system has been seen in diabetics with hypertension and this has been 
attributed to the accelerated atherosclerosis. This premature ageing probably 
contributes to the isolated systolic hypertension and decreased baroreceptor sensitivity 
that is seen more commonly in young diabetics with hypertension. The role of 
hyperinsulinemia and insulin resistance in linking diabetes, hypertension and 
dyslipidaemia has been studied. Observations that have been made include, higher 
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levels of triglycerides and low High density lipoproteins in associated with 
hyperinsulinemia and insulin resistance. Hyperinsulinemia has also been shown to 
interfere with fibrinolysis as evidenced by higher levels of fibrinogen and 
Plasminogen activator inhibitor. In tissue culture, insulin has been shown to induce 
sub-intimal smooth muscle and fibroblast proliferation, which could result in an 
acceleration of the atherosclerotic process. Thus, hyperinsulinemia that is associated 
with diabetes and obesity could result in an acceleration of atherosclerosis resulting in 
hypertension (35) 
 
x) Obesity and hypertension 
The relationship between obesity and hypertension can be seen from childhood. Even 
at an early age, as body weight and adiposity increase, blood pressure rises. The 
distribution of fat is also important, with central obesity being associated with more 
insulin resistance and there by resulting in hypertension. 
The risk of hypertension is five times more in obese individuals in comparison to 
those whose weight is normal (36). The cause for the hypertension related to obesity 
has been attributed to higher levels of angiotensinogen that is released from 
adipocytes which acts to raise blood pressure, a greater blood volume that is 
associated with an increased body mass and an increase in blood viscosity that is 
caused by an increase in profibrinogen and plasminogen activator inhibitor 1 that are 
released by adipocytes (37).  
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As the Body mass index increased above 21 Kg/Mt², the risk of dyslipidaemia rises 
with rising Low Density Lipoprotein (LDL) levels which is an important risk factor 
for coronary heart disease.  Low High Density Lipoprotein (HDL) with high levels of 
triglycerides further increases the risk of coronary heart disease.  
 
xi) Stress and hypertension: 
 
Stress can be defined as a pathological process within the body to external stimulus 
and abnormal states that affects its homeostasis. Stressors of an emotional nature 
result in psychological stress. The stressors of modern life are related to work, family, 
finances, health, and societal pressures. All of these can contribute to hypertension in 
the long run. 
 
The relationship between stress and hypertension has been studied with the 
elaboration of various pathophysiological mechanisms.  
In the acute setting, stress, results in an increased blood pressure by increasing the 
cardiac output and heart rate without changing the total peripheral resistance. Levels 
of certain hormones like catecholamines, cortisol, aldosterone, vasopressin and 
endorphins that may partly explain the increase in blood pressure.  This heightened 
sympathetic response in the long term could result in vascular remodelling, resulting 
in hypertension. Stress could also indirectly contribute to hypertension through 
associated factors like over eating, obesity, alcohol use and physical inactivity.  
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A primary activation of the sympathetic nervous system has also been suggested. 
Acute stress is also known to cause a decrease in urinary sodium excretion, which also 
contributes to hypertension. “ white-coat hypertension” is well known to occur due to 
stress, and in such a setting, the need for ambulatory blood pressure monitoring is 
needed (38). 
 Prospective studies looking at blood pressure reactivity and the risk of developing 
hypertension, have shown that individuals with higher blood pressure reactivity during 
stressful tasks had a greater odds of developing hypertension. The same was noted of 
those whose blood pressure remained high during the recovery period following 
completion of the stressful task. 
A study among Information Technology professionals, found a high prevalence of 
hypertension (31%) and prehypertension( 45.7%) with high work place related stress 
(39).  
The role of relaxation techniques to decrease stress and thereby blood pressure is 
being acknowledged more and more 
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xii) Diet and hypertension 
 
 
With time, changes in dietary patterns have contributed to an increase in non-
communicable diseases like Hypertension, Diabetes mellitus and Dyslipidaemia. 
Globalisation has also resulted in a more widespread consumption of foods high in 
salt, sugar, refined starch and unhealthy fats.  
It is well known that various dietary factors influence blood pressure.  These include 
weight control, decreased consumption of salt, increased consumption of potassium 
and reduced alcohol consumption.  
Salt: 
Rising dietary salt has been seen to cause a rise in blood pressure. This observation 
has been backed by data from animal studies, epidemiological studies and meta-
analyses of clinical trials. The INTERSALT study, was an epidemiological study with 
10,079 subjects from 32 countries, which found a positive lineal relation between 
systolic blood pressure and twenty four hour sodium excretion. They also noted that a 
100 mmol per day higher consumption of sodium a day was associated with a higher 
systolic and diastolic blood pressure of 3-6/0-3 mm Hg. This relation was noted in 
both sexes and also across age groups (40).  
A meta-analysis of  randomised trials comparing modest reductions in salt intake 
versus regular salt intake for a period of at least 4 weeks, found that a reduction of 6 
grams of salt a day resulted in 7.11/3.88 mm Hg fall in blood pressure in hypertensive 
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individuals and a 3.57/1.66 mm Hg fall in blood pressure in normotensive individuals 
(41).  
The DASH study showed that the DASH diet ( rich in fruit, vegetables, low fat dairy 
foods, fibre and protein and with reduced quantities of saturated fat and cholesterol ) 
resulted in a reduction in systolic blood pressure by 5.5 mm Hg and diastolic blood 
pressure of 3.0 mm Hg (42). 
A subsequent study showed that the combination of a low salt diet to the DASH diet, 
showed lowered the systolic blood pressure by 11.5 mm Hg in patients with 
hypertension and 7.1 mm Hg in non-hypertensive patients. The combination of the 
two interventions together was as effective as a single antihypertensive agent (43). 
The greatest effect on blood pressure due to sodium reduction has been seen in blacks, 
middle aged and older persons, and in persons with hypertension, diabetes or chronic 
kidney disease.  This subset of persons have been found to have a renin – angiotensin 
– aldosterone system that is less responsive (44). 
Population studies in India have been done to estimate salt intake. The CURES-53 
study, estimated the dietary salt consumption in an urban population in South India, 
and found that the mean daily salt intake was 8.5 grams per day. They also found that 
those with a higher salt intake had a higher prevalence of hypertension. Increase in 
dietary salt was seen to correlate with increases in both systolic and diastolic blood 
pressures of those with hypertension and also among those with normal blood 
pressures. They also found a higher prevalence of hypertension among those who 
added more than a teaspoon of salt a day to their food (45). 
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Potassium: 
Evidence from animal studies, observational studies and meta-analyses of clinical 
trials have shown that a high potassium intake is associated with lower blood pressure.  
This has been seen in both subjects with and without hypertension.  
A meta-analysis of 19 studies showed that an increased urinary potassium excretion of 
2 grams per day resulted in blood pressure reductions of 4.4/2.5 mm Hg in subjects 
with hypertension and 1.8/1.0 mm Hg in those without hypertension (46) 
Diets that consume more fruits and vegetables are rich in potassium and with the 
added benefit of other nutrients that they contain are recommended over potassium 
containing supplements.  
The effect that potassium has on blood pressure, has been found to depend on 
concurrent salt intake, with the greatest blood pressure lowering effect of increased 
potassium intake seen at higher levels of salt consumption. The opposite also being 
true with the maximal reduction in blood pressure due to decreased salt intake being 
maximal at low potassium intake.  
 
 
Alcohol consumption and hypertension 
 
Alcohol intake is associated with a direct dose-dependent relationship with 
hypertension, with this effect being seen once the quantity of alcohol increased to 
more than two drinks a day. The relationship between alcohol and hypertension has 
been found to be independent of other factors like age, salt intake and obesity.  
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Some studies have also shown that drinking less than or equal to two drinks a day, 
may reduce the risk of coronary heart disease.  
 A meta-analysis of fifteen RCTs showed that a decrease in alcohol consumption 
resulted in reduced systolic and diastolic blood pressure by 3.3/2.0 mm Hg. These 
reductions were seen in both hypertensive and non-hypertensive subjects (47). 
As per current guidelines, alcohol consumption should be limited to less than two 
standard drinks in men and one drink in women and lighter-built persons.  
Saturated fats 
 
Prospective studies like the Nurses’ Health Study and the Health Professional Follow 
up Study did not find an association between saturated fat and hypertension (48,49).  
Most trials that have tested the role of fat on hypertension have usually combined 
reduced saturated fat with increased polyunsaturated fat and have not been able to 
show an effect.  
 
Fibre 
 
Dietary fibre consists of the indigestible parts of plants in food. Evidence is still varied 
on the effect of fibre on blood pressure. A large number of studies that have looked at 
various foods and their effect on blood pressure, have  
A meta-analysis of trials has found that increased fibre intake in the form of 
supplemental fibre was associated with a reduction in systolic and diastolic blood 
pressure of  1.6/2.0 mm Hg (50). This could not be substantiated in a randomized 
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clinical trial. It suffices to say that at present the data on the effect of dietary fibre on 
blood pressure is insufficient and further studies are needed.  
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4 Methodology 
 
4.1 Study setting: 
 
The study was conducted in the Department of General Medicine at the Christian 
Medical College Hospital, Vellore.   
 
4.2 Study design:  
 
This is a prospective descriptive study. 
4.3 Study period: 
 
September 2014 to September 2015. 
 
4.4 Inclusion criteria: 
 
1. Patients presenting with hypertension, diagnosed between the ages of 18 and 40, 
attending the General Medicine Outpatient department. 
2. The cut off for hypertension as per the JNC 7 guidelines is taken as a BP of ≥ 
140/90mmHG. This is to be the average of two readings. 
3. Patients may already have been evaluated for a secondary cause or may be 
undergoing evaluation. 
 
4.5 Exclusion criteria: 
 
1. Subjects unwilling to give consent. 
2. Pregnant women 
33 
 
 
4.6 Sample size calculation: 
 
Studies on the epidemiology of secondary causes of hypertension in the young in India 
are sparse. A study conducted by Raluca et al in Romania (2012) found a prevalence of 
endocrine causes to be 20% in young hypertensive patients. 
This study’s prevalence of hypertension has been used to calculate the sample size. 
 p: 20% 
 q: 80% 
d: being the allowable error = 6 
Using the formula: 4pq/d2  
The sample size was calculated to be 178. 
 
4.7 Method of recruitment: 
Approval was obtained from the Institutional Review Board and Ethics committee.  
(IRB Min No 9079).  
Patients presenting to the General Medical OPD at the Christian Medical College 
Hospital were recruited based on the case definition and eligibility criteria. 
The recruitment was based on convenience sampling. 
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4.8 Method of evaluation: 
1. Informed consent was obtained and patient confidentiality assured. 
2. A questionnaire was used to collect details with regards to demography and the 
history of hypertension. 
3.  A detailed clinical examination was performed. 
4. Measurements of height, weight, blood pressure, hip circumference, waist 
circumference and body composition were taken. 
5. A stress questionnaire was administered. 
6. A dietary evaluation was done by a dietician 
7. An exercise evaluation was done by a physiotherapist. 
8. Laboratory test results were obtained from the electronic medical records. 
 
 
 
Measurements taken: 
Blood pressure:  
The auscultatory method of blood pressure measurement was taken with a properly 
calibrated and validated instrument. Subjects were quietly seated for at least 5 minutes 
in a chair, with both feet on the floor and the arm supported at the level of the heart.  
An appropriate sized cuff (with the cuff bladder encircling at least 80% of the arm) 
was used. An average of two measurements were taken. The systolic blood pressure 
was taken at the point when the first of two or more sounds are heard and the diastolic 
blood pressure the point just before the disappearance of the Korotkoff sounds.   
35 
 
 
 
Height: 
This was measured using a validated calibrated measuring scale. Measurements were 
taken to the nearest centimetre. 
Weight: 
This was measured using a validated calibrated weighing scale. Measurements were 
taken to the nearest kilogram. 
Waist circumference: 
This was measured using an inch tape, and as per the WHO, the measurement was 
taken at the midpoint between the lowest palpable rib and the top of the iliac crest.  
The subject was standing, arms by the side, with the feet together and with the weight 
distributed evenly across the feet. 
Hip circumference: 
This was measured using an inch tape, with the measurement being taken at the widest 
portion of the buttocks, with the tape parallel to the ground.  The subject was standing, 
arms by the side, with the feet together and with the weight distributed across the feet.  
General physical examination: 
A Physical examination was conducted with special emphasis to the following: 
1. Acanthosis nigricans 
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2. Signs of hypothyroidism 
3. Signs of hyperthyroidism 
4. Signs of Cushing’s syndrome 
5. Renal artery bruit 
5. Peripheral pulses 
Body fat analysis: 
This was done using a validated body fat analyser. 
Stress assessment:  
The tool used to assess stress was the Cohen perceived stress questionnaire. This is a 
ten question questionnaire that assess perceived stress over the past month. This was 
administered by the Principal investigator.  
Dietary assessment: 
A ten part food frequency questionnaire was administered by a dietician. Dietary 
practices based on the DASH (Dietary approaches to stop hypertension) diet were 
incorporated into the questionnaire. These included salt, fruit and vegetable, saturated 
fat intake. 
Physical activity assessment: 
This was done by a physiotherapist, who administered the Long form of the 
International Physical Activity Questionnaire (IPAQ). Assessment of physical activity 
in the following domains were made: 
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1. Leisure time 
2.  Domestic and gardening activities 
3. Work – related and transport – related activities. 
Based on this, the Metabolic equivalents (Mets) were calculated and physical activity 
grouped into low (less than 600 Mets), medium (600 to 3000 Mets) and high (more 
than 3000 Mets). 
DATA variables assessed: 
The following variables were assessed: 
A. Demographic details:  
a. Age 
b. Sex 
c. Age of onset 
d. Residence 
B. History pertaining to hypertension:  
a. Duration of hypertension 
b. Symptoms at onset 
c. Anti-hypertensive use 
C. Risk factors for hypertension: 
a. Family history of hypertension 
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b. Other drug use 
c. History of diabetes mellitus 
d. History of Dyslipidaemia 
e. History of smoking 
f. History of alcohol use 
g. Symptoms of Pheochromocytoma 
h. Symptoms of Hypothyroidism 
i. Symptoms of hyperthyroidism 
j. Symptoms of Cushing’s syndrome 
k. Symptoms of Obstructive sleep apnoea 
l. Symptoms of chronic renal failure 
D. Measurements: 
a. Height 
b. Weight 
c. Waist circumference:  
For men, a waist circumference more than 90 centimetres and for women more than 
80 centimetres was taken as a cut-off for central obesity. 
d. Hip circumference 
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e. Waist-hip ratio:  
For men a cut-off of more than 0.9 was taken as suggestive of central obesity and for 
women a cut-off of 0.85 was taken.  
Body mass index (BMI): The indexes for the same were as per the WHO guidelines 
for BMI for Asians: 
Underweight: < 18.5 Kg/Mt² 
Normal: 18.5 – 22.9 Kg/Mt² 
Overweight: 23 to < 25 Kg/Mt² 
Obesity I: 25 to 29.9 Kg/Mt² 
Obesity II: ≥ 30 Kg/Mt² 
 
f. Blood pressure 
g. Percentage body fat: 
In men, a percentage of body fat above 25% was considered high and for women 
above 32%.  
g. General physical examination for acanthosis nigricans, signs of hypothyroidism, 
hyperthyroidism, Cushing’s syndrome, renal artery bruit and peripheral pulses.  
E. Stress assessment 
F. Dietary evaluation 
G. Physical activity assessment 
H: Laboratory parameters: 
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This data was obtained from the electronic medical records and comprised the 
following: 
a. Creatinine 
b. Fasting sugars 
c. Post prandial sugars 
d. HbA1c 
e. TSH 
f. 8AM cortisol 
g. Urine metanephrines 
h. Electrocardiogram: 
 Left ventricular hypertrophy was assessed by the Sokolov- Lyon criteria: 
S wave depth in V1 + the tallest R wave height in leads V5/V6 to be > 35 mm 
i. Echocardiogram 
j. Renal artery Doppler 
k. Serum potassium 
l. Serum fasting lipids 
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Statistical Analysis: 
 
Demographic data was analysed with descriptive statistics. Continuous variables were 
expressed as mean ± SD, or median with range. Categorical variables were expressed 
as frequencies and percentages. Comparison of different groups based on categorical 
variables was done by Chi- square test.  
Comparison of different groups was done by the two-tailed t test and Mann-Whitney 
test. P <0.05 was be considered to be statistically significant. 
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Figure 1: Study flow diagram:  
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5 Results: 
 
5.1 Distribution of Primary and Secondary hypertension 
 
The following is a description of the young hypertensive patients included in this 
study. 85 patients were included in this study from September 2014 to September 
2015. There were 54 men and 31 women. 
 Nine (10%) of the patients were newly diagnosed with hypertension and another 9 
(10%) had been recruited within a month of diagnosis. Of the 85 patients, 9 (11%) 
were found to have a secondary cause for the hypertension and the remaining were 
categorised as having Primary hypertension. 
The patients were evaluated by a limited screen for secondary causes of hypertension. 
Based on this, the distribution of primary and secondary causes is as follows: 
 
 
Figure 2: Distribution of hypertensive subjects   (N=85) 
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5.2 Geographic distribution of the Subjects: 
 
 CMCH is a tertiary hospital and caters to patients from all over the country as well as 
those from neighbouring countries. Approximately 36% of the subjects were from 
Tamil Nadu, this was followed in number by subjects from West Bengal and 
Bangladesh. 
 
 
Figure 3: Geographical distribution of subjects   (N=85) 
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5.3 Duration of hypertension: 
The duration of hypertension was less than a year in approximately half the study 
group. And only 15% had a duration of hypertension that was more than 6 years. 
 
Figure 4: Duration of hypertension (N=85) 
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5.4 Evaluation for secondary hypertension 
 
Of the 85 study subjects, 11% (9) were found to have a secondary cause for the 
hypertension. Of the 85 subjects, in the study, the following is the distribution of tests 
done.  
 
History:  
Part of the history obtained from subjects, pertained to that of symptoms due to a  
Secondary cause. Of the 85 subjects, 8, had a history suggestive of obstructive sleep 
apnoea (using the STOP BANG screen), 6 had a history suggestive of 
pheochromocytoma (paroxysms of headache, palpitations and tremors) and 1 had 
symptoms suggestive of hypothyroidism.   
Sl No History suggestive of secondary hypertension Number 
1 Symptoms of renal disease 0 
2 Symptoms of Cushing’s syndrome 0 
3 Symptoms of pheochromocytoma 6 
4 Symptoms of hyperthyroidism 0 
5 Symptoms of hypothyroidism 1 
6 Symptoms of obstructive sleep apnoea 8 
 
Examination: 
On examination, 17 subjects, were found to have acanthosis nigricans. One subject 
each had signs of hypothyroidism and Cushing’s syndrome. 
Sl No Signs on examination Number 
1 Acanthosis nigricans 17 
2 Signs of hyperthyroidism 0 
3 Signs of hypothyroidism 1 
4 Signs of Cushing’s syndrome 1 
5 Renal bruit 0 
6 Absent peripheral pulses 0 
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Laboratory Investigations: 
A limited secondary hypertension screen was done for most subjects. All tests were 
not done for subjects, as these were tests that were done at the discretion of the 
treating physician. 
 
Sl No Test Number 
1 Creatinine 80 
2 Potassium 60 
3 Urine sediments 56 
4 Renal artery Doppler 36 
5 Total cholesterol 63 
6 Triglycerides 64 
7 HDL 63 
8 LDL 68 
9 Fasting glucose 63 
10 Post prandial glucose 58 
11 HbA1c 12 
12 TSH 66 
13 Cortisol 34 
14 Urine metanephrines 52 
15 ECG 54 
16 ECHO 24 
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5.5 Symptoms at presentation: 
 
Of the 85 subjects, hypertension was detected incidentally in 60% (51). 35% (30) had 
CNS symptoms at presentation. Of these, 16% (14) had dizziness, 13% (11) had 
headache and 6% (5) had a cerebrovascular accident.  
 
 
Figure 5: Symptoms at presentation (N=85) 
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5.6 Profile of patients with Secondary hypertension: 
 
 
Sl 
N
o 
Symptoms Signs Investigations Diagnosis 
1 Pedal edema x 
1 year 
Obese 
Acanthosis 
nigricans 
TSH 99.9 uIU/ml 
Anti-thyroglobulin 
Ab:27 IU/ml 
Anti-microsomal 
AB:585 IU/ml 
Primary hypothyroidism 
2 Exertional 
dyspnoea x 2 
years 
Pallor Creatinine:6mg % 
Urea: 56mg% 
Hb 7.2 gm/DL 
 
Chronic kidney disease 
3 Dizziness x 6 
months 
- Creatinine:8.4 
mg% 
Urea: 118mg% 
Hb:5.9GM/DL 
USG: Bilateral 
kidneys showed 
grade II 
parenchymal 
changes 
Chronic kidney disease 
4 Headache x 5 
days 
- Creatinine:3.5mg% 
Urea: 54 mg% 
Proteinuria:1.4G/2
4 hours 
USG: Bilateral 
grade II renal 
parenchymal 
changes 
Chronic kidney disease 
Renal biopsy: 
Arteriolonephrosclerosi
s with chronic 
interstitial nephritis 
5 Headache x 6 
months 
CVS: EDM 
at the aortic 
area 
ECHO: Severe 
Aortic 
regurgitation 
Aortic regurgitation  
(severe) 
6 Increased 
weight gain x 
7 years 
Proximal 
weakness x 1 
month 
Over the 
counter 
medication 
use + 
Cushingoid 
facies 
Dorsocervica
l pad of fat 
Proximal 
weakness 
8 Am Cortisol: 
0.28 ug% 
Exogenous 
Cushing’syndrome 
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7 Headache 
Blurring of 
vision 
Seizures 
- Creatinine: 
0.85mg% 
Urine Protein: 
3G/24 hours 
Nephrotic syndrome 
Renal biopsy: Dense 
deposition disease 
8 Asymptomati
c 
- TSH 25uIU/ml Primary hypothyroidism 
9 Asymptomati
c 
- TSH 60 uIU/ml Primary hypothyroidism 
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5.7 Profile of patients with Primary hypertension: 
 
1) Demographic details: 
a) Age:  
In those with Primary hypertension, 72% (55) of the patients were between the age 
groups of 31 and 40 and 28% (21) were between the age groups of 18 to 30 years. 
The age of onset of hypertension was less than thirty years in 45% (34) of the subjects 
and over the age of thirty in 55% (42). 
 
 
Figure 6: Age distribution (N=76) 
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Figure 7: Age of onset (N=76) 
 
 
 
 
b) Gender: 
 
Among the 76 subjects with Primary hypertension, there were more men than women 
with 64% (49) men and 36% (32) women. 
 
 
Figure 8: Gender (N=76) 
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c) Residence: 
With regards to the nature of residence, 66% (50) were from an Urban residence and 
34% ( 26 ) were from a Rural residence.  
 
Figure 7: Residence             (N=76) 
 
 
 
2) Risk factors: 
a) Family history of hypertension: 
 
There was a positive family history of hypertension in 70% (53) of the subjects with 
primary hypertension as compared to 30% (23) who did not.
 
Figure 8: Family history of hypertension (N=76) 
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b) Diabetes mellitus: 
Of the 76 patients with primary hypertension, 8 (11%) had co existing diabetes 
mellitus as well. 
 
Figure 9: Diabetes mellitus (N=76) 
 
 
 
 
c) Dyslipidaemia:  
Among those with primary hypertension, 39% (30) also had dyslipidaemia and 61% 
(46) did not. 
 
Figure 10: Dyslipidaemia (N=76) 
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d) Obesity:  
 
The number of obese subjects was 61% (47) among those with primary hypertension. 
 
Figure 11: Obesity (N=76) 
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e) Waist circumference: 
Among men, 65% (28) had a waist circumference that was more than 90 centimetres 
and 35% (15) had a waist circumference that was less than 90 centimetres. Among 
women, 81% (22) had a waist circumference that was more than 80 centimetres and 
19% (5) had a waist circumference that was less than 80 centimetres.
 
Figure 12: Waist circumference (Men) (N=43) 
 
 
 
Figure 13: Waist circumference (women) (N=27) 
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f) Waist-hip ratio: 
Among men, 74% (32) had a waist- hip ratio that was more than 0.9 and 26% (11) had 
a waist-hip circumference that was less than 0.9. Among women, 64% (16) had a 
waist-hip ratio that was more than 0.85 and 36% (9) had a waist-hip circumference 
that was less than 0.85. 
 
 
Figure 14: Waist-hip ratio (Men) (N=43) 
 
 
Figure 15: Waist-hip ratio (Women) (N=25)  
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g) Percentage body fat: 
 
Figure 16: Percentage body fat (N=69)  
 
h) Alcohol use and hypertension: 
Alcohol use was reported in 16% (12) of the subjects with primary hypertension. 
 
Figure 17: Alcohol use (N=76)  
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i) Tobacco use and hypertension:  
Tobacco use: Of the 76 subjects, tobacco use was documented in 16% (12). 
 
Figure 18: Tobacco use (N=76)  
 
 
 
 
 
j) Stress: 
 Among those with Primary hypertension, High stress was perceived in 46% (30) and 
low stress in 54% (35).  
 
Figure 19: Stress (N=65)  
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k) Physical activity and hypertension: 
Of the 42 patients who underwent a physical activity evaluation, 29% (12) had low 
levels of activity, 45% (19) had medium levels of activity and 26% 11) had high levels 
of activity. 
 
Figure 20: Physical activity and hypertension (N=42) 
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k) Added salt: 
Of the 55 patient who underwent a dietary evaluation, 91% (50) added salt to their 
food and 9% (5) did not.
 
Figure 21: Added salt (N=55)  
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l) Fruit and vegetable servings per day 
Of the 55 subjects who underwent a dietary evaluation, 55% (30) consumed less than 
three servings of fruit and vegetables per day as compare to 45% (25) who consumed 
more than three servings per day. 
 
Figure 22: Fruit and Vegetable servings per day (N=55) 
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3) Target organ damage: 
Left ventricular hypertrophy: Of the 54 subjects who underwent an electrocardiogram, 
37% (20) had left ventricular hypertrophy, while 63% (34) did not. 
  
 
Figure 23: Left ventricular hypertrophy (N=76)  
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4) Control of blood pressure: 
Among the 76 subjects, only 40% (30) were well controlled (blood pressure < 140/90 
mm Hg), the remaining 60% (46) were not well controlled.  
 
Figure 24: Control of blood pressure 
 
Figure 25: Type of antihypertensive use (N=76)  
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Based on the baseline characteristics, further analysis was carried out. With the 
demographic distribution showing a predominance of subjects from Tamil Nadu, West 
Bengal and Bangladesh, a comparison was done between these groups to look for any 
differences in the risk factors for hypertension between from South India and North-
East India/Bangladesh. 
 
The difference in gender showed more men as compared to women. This could 
represent an actual difference in hypertension between these two groups or a 
difference in health seeking behaviour. Hence these two groups – that is men and 
women were also compared to study any difference in the modifiable risk factors 
between these two groups.  
Primary hypertension is considered a part of the metabolic syndrome, being associated 
with diabetes, dyslipidaemia and central obesity. 
The number of subjects with obesity was found to be 61% (47). Hence a comparison 
was done between those with and without obesity, to look for other differences in the 
modifiable risk factors between these two groups. 
Epidemiological studies have shown the prevalence of hypertension to be more in 
urban than rural populations. A note has also been made of the steadily increasing 
prevalence of hypertension among rural residents.  
This study showed a predominance of urban residents with 60% (50) subjects from an 
urban residence and 40% (26) from a rural one. Thus, a comparison was also made 
between subjects living in rural and urban residences. 
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1. Tamil Nadu vs West Bengal/Bangladesh 
 
Sl No Variable Tamil Nadu W.B/Bangladesh P value 
1 Age:                  18-30 15% (4) 33% (9) 0.12 
                           31 - 40 84% (22) 67% (18)  
2 Gender:             Male 65% (17) 66% (18) 0.92 
                           Female 35% (9) 34% (9)  
3 Age of onset:    18 – 30 31% (8) 63% (17) 0.01 
                           31 - 40 69% (17) 37% (10)  
4 Family history:   Yes 62% (16) 78% (21) 0.19 
                             No 38% (10) 22% (6)  
5 Residence:          Urban 71% (22) 43% (12) 0.26 
                            Rural 29% (9) 57% (16)  
6 Diabetes:            Yes 0% (0) 15% (4) 0.04 
                             No 100% (26) 85% (23)  
7 Dyslipidaemia:   Yes 31% (8) 56% (15) 0.06 
                             No 69% (18) 44% (12)  
8 Obesity:              Yes 58% (15) 60% (16) 0.90 
                             No 42% (11) 40% (11)  
9 Alcohol use:       Yes 19% (5) 4% (1) 0.07 
                             No 81% (21) 96% (26)  
10 Stress:                 High 48% (12) 52% (11) 0.76 
                             Low 52% (13) 48% (10)  
11 Physical activity: Low-
medium 
75% (9) 86% (12) 0.51 
                              High 25% (3) 14% (2)  
12 Diet – Added salt: Yes 89% (16) 86% (19) 0.52 
                                No 11% (2) 14% (3)  
 
Epidemiological studies in India, have shown a geographical difference in the 
prevalence of hypertension among various states. There has also been a difference in 
the risk factors. 
With the majority of subjects, in this study from Tamil Nadu, West Bengal and 
Bangladesh, a comparison was done between the subjects from South India and from 
the eastern part of the country and the adjacent country of Bangladesh.  
1. Age: 
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 With regard to the age of the subjects, it was found that in the age group of 18 – 30, 
the number of subjects from West Bengal / Bangladesh [33% (9)], was twice that of 
those from Tamil Nadu [15% (4)], with a trend to significance.  
There was a statistically significant difference in the age of onset, with the subjects 
from Tamil Nadu, having an older age of onset [69% (17)] as compared to those from 
West Bengal / Bangladesh [37% (10)].  
 
2. Gender: 
With regards to gender, the distribution of male and female subjects was similar in 
both groups. 
 
3. Risk factors: 
A difference in the risk factors associated with hypertension showed a statistically 
significant difference between the two groups with respect to diabetes mellitus and 
trend to significant with respect to dyslipidaemia and alcohol use.  
Diabetes mellitus: The prevalence of diabetes mellitus was 15% (4) among those 
from West Bengal / Bangladesh as compared to 0% from Tamil Nadu.  
Dyslipidaemia and obesity: The prevalence of dyslipidaemia in the subjects from 
West Bengal / Bangladesh was 56% (13) in comparison to those from Tamil Nadu 
31% (8). When looking at obesity though the prevalence between both groups was 
similar, with 58% (15) from Tamil Nadu and 60% (16) being obese.  
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Stress: The difference in stress both groups was similar with high levels of perceived 
stress among 48% (12) of those from Tamil Nadu as compared to 52% (11) from West 
Bengal / Bangladesh. 
Physical activity: The majority of subjects from both Tamil Nadu 75% (9) and West 
Bengal / Bangladesh 86% (12), had low - moderate levels of physical activity, which 
could be contributing to the hypertension. 
Salt intake: The majority of subjects from both Tamil Nadu 89% (16) and from West 
Bengal / Bangladesh 86% (19), added salt to their daily food intake. 
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2. Men Vs Women 
 
Sl no Variable Men Women p 
value 
1 Age :              18 – 30 42% (16) 22% (7) 0.48 
                        31 – 40 58% (38) 78% (24)  
2 Age of onset: 18 – 30 44% (24) 42% (13) 0.82 
                        31 – 40 56% (30) 58% (18)  
3 Residence:      Urban 
                        Rural 
73% (38) 
 27% (15) 
54% (17) 
45% (14) 
0.10 
4 Family history: Yes 76% (41) 61% (19) 0.15 
                           No 24% (13) 39% (12)  
5 Diabetes mellitus: Yes 9% (5) 19% (6) 0.18 
                                No 91% (49) 81% (25)  
6 Dyslipidaemia: Yes 43% (23) 32% (10) 0.34 
                           No 57% (31) 68% (21)  
7 Alcohol use:     Yes 25% (14) 3% (1) 0.008 
                           No 75% (40) 97% (30)  
8 Obesity:            Yes 66% (30) 35% (11) 0.04 
                           No 34% (24) 65% (10)  
9 Stress:              High 44% (22) 48% (10) 0.78 
                              Low 56% (28) 52% (11)  
10 Physical activity: Low-Medium 76% (25) 64% (9) 0.47 
                              High 24% (8) 36% (5)  
11 Diet:           
 
When men and women were compared, the following was found: 
1. Age: 
 With regard to the age of the subjects and the age of onset of hypertension, there was 
no statistically significant difference. Both groups were predominantly between the 
ages of 31 to 40, with 58% (38) men and 78% (24) women in this age group. The age 
of onset of hypertension, was equally divided between men and women. 
  
2. Risk factors: 
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With respect to the risk factors of hypertension, there was a difference in the risk 
factors of residence, family history of hypertension and diabetes mellitus, with a trend 
to significance. There was a statistically significant difference between the two groups 
with respect to alcohol use and obesity.  
The incidence of obesity among men was 66% (30) as compared to 35% (11) in 
women and was statistically significant. There was also no statistically significant 
difference between the two groups with respect to stress levels, physical activity or 
salt intake.  
 
 
3. End organ damage – Left ventricular hypertrophy 
There was also no statistically significant difference between the two groups with 
respect to left ventricular hypertrophy.  
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3. Obese vs Non-obese:  
The following is a comparison between the Obese and Non-obese subjects with 
primary hypertension. 
 
Sl No Variable Non-Obese Obese P value 
1 Age:                  18 – 30 48% (14) 15% (7) 0.002 
 31 – 40 52% (15) 85% (40)  
2 Gender:             Male 72% (21) 60% (28) 0.25 
                           Female 28% (8) 40% (19)  
3 Age of onset:    18 – 30 59% 
 (17) 
36% (17) 0.05 
                           31 – 40 41% (12) 64% (30)  
4 Family history: Yes 66% (19) 72% (34) 0.52 
                           No 34% (10) 28% (13)  
5 Residence:        Rural 31% (9) 36% (17) 0.64 
                           Urban 69% (20) 64% (30)  
6 Diabetes:           Yes 7% (2) 13% (6) 0.41 
                           No 93% (27) 87% (41)  
7 Dyslipidaemia:  Yes 38% (11) 40% (19) 0.82 
                           No 62% (18) 60% (28)  
8 Alcohol use:      Yes 14% (4) 17% (8) 0.70 
                            No 86% (25) 83% (39)  
9 Stress:                High 46% (12) 46% (18) 1.0 
                            Low 54%(14) 54% (21)  
10 Physical activity: Low-
medium 
80% (12) 70% (19) 0.46 
 High: 20% (3) 30% (8)  
11 Added salt:        Yes 90% (18) 91% (32) 0.85 
                            No 10% (2) 9% (3)  
12 LVH:                  Yes 45% (10) 28% (10) 0.16 
                            No 55% (12) 73% (26)  
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These were the observations on comparing subjects with and without obesity: 
1. Age:  
 With regard to the age of the subjects, there was a statistically significant difference 
between those with and without obesity. Among those with obesity, [85% (40)] were 
older than 30 years as compared to only [52% (15)] of those without obesity. In those 
without obesity, the age distribution between those less than 30 [48% (14)] and more 
than 30 [52% (15)] was roughly the same.  
Among those with obesity, a significantly larger number, [64% (30)] developed 
hypertension before the age of 30, as compared to those without obesity [41% (12)]. 
2. Gender: 
With regards to gender, the distribution of male and female subjects was similar in 
both groups. 
3. Risk factors: 
Analysis of the risk factors associated with hypertension did not show a statistical 
difference between those with and without obesity for a family history of 
hypertension, diabetes mellitus, dyslipidaemia, residence and alcohol use. 
There was also no statistically significant difference between the two groups with 
respect to stress levels, physical activity or salt intake.  
 
 
 
74 
 
 
4. End organ damage – Left ventricular hypertrophy 
Though left ventricular hypertrophy was seen more among those without obesity 
[45% (10)], as compared to those with obesity [28% (10)], the difference was not 
statistically different.  
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4. Urban vs Rural: 
Sl No Variable Rural Urban P value 
1 Age:                  18 – 30 27% (7) 28% (14) 0.92 
                           31 – 40 73% (19) 72% (36)  
2 Gender:             Male 54% (14) 70% (35) 0.16 
                           Female 46% (12) 30% (15)  
3 Age of onset:    18-30 35% (9) 50% (25) 0.21 
                           31 – 40 63% (17) 50% 25)  
4 Family history:  Yes 54% (14) 78% (39) 0.03 
                            No 46% (12) 22% (11)  
5 Diabetes:            Yes 12% (3) 10% (5) 0.83 
                             No 88% (23) 90% (45)  
6 Dyslipidaemia:   Yes 42% (11) 38% (19) 0.71 
                             No 58% (15) 62% (31)  
7 Alcohol use:       Yes 7% (2) 20% (10) 0.16 
                             No 92% (24) 80% (40)   
8 Stress:                 High 40% (8) 49% (22) 0.50 
                             Low 60% (12) 51% (22)  
9 Physical activity: Low-
medium 
69% (9) 76% (22) 0.83 
                              High 31% (4) 24% (7)  
10 LVH:                    Yes 36% (8) 33% (12) 0.81 
                               No 64% (14) 67% (24)  
 
On comparing subjects from Rural and urban residences, the following differences 
were found. 
1. Age: 
 With regard to the age of the subjects and the age of onset of hypertension, there was 
no statistically significant difference.   
2. Gender: 
With regards to gender, the distribution of male and female subjects was similar in 
both groups. 
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3. Risk factors: 
The only statistically significantly risk factor for hypertension between those from 
rural and urban residences was a family history of hypertension. Among those from an 
urban residence, the prevalence of hypertension was 78% (38), as compared to 54% 
(14) living in a rural area. 
There was also no statistically significant difference between the two groups with 
respect to stress levels, physical activity or salt intake.  
 
4. End organ damage – Left ventricular hypertrophy 
There was also no statistically significant difference between the two groups with 
respect to left ventricular hypertrophy.  
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DISCUSSION: 
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The following is the discussion of the results and analysis from this study. 
a) Evaluation of secondary hypertension:  
 
The evaluation for a secondary cause for the hypertension was based on a combination 
of history, physical findings and laboratory tests. 
i. History:  
This study found that a majority of subjects [60% (51)] were asymptomatic for the 
hypertension. This is in keeping with hypertension being called the “silent killer” as 
most patients are usually asymptomatic. Among those who were symptomatic, the 
commonest symptoms were those of dizziness and headache. A few patients also had 
symptoms of epistaxis and palpitations. It is also important to note that 5 patients 
presented with a stroke.  
With regards to the history of symptoms suggestive of secondary causes of 
hypertension, 18% (15) subjects had symptoms. Of these the commonest were 
symptoms of obstructive sleep apnoea and symptoms of pheochromocytoma. 
None of the patients who had symptoms suggestive of obstructive sleep apnoea 
underwent a sleep study to confirm the presence of obstructive sleep apnoea. 
The symptoms of pheochromocytoma are nonspecific and screening by urinary 
metanephrines and normetanephrines was not suggestive of the same. Studies have 
shown that this test has a sensitivity of  94% and specificity of 84% (51).  
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b. Examination: 
Examination for signs of secondary hypertension, revealed only two subjects to have 
signs of secondary hypertension, with one having signs of Cushing’s disease and the 
other signs of hypothyroidism. This is in keeping with other studies where physical 
examination was found to have a low sensitivity for diagnosing secondary causes of 
hypertension (15).  
c. Laboratory tests: 
The evaluation for secondary causes of hypertension in this study was inadequate. 
This was largely due to the fact that the laboratory evaluation for secondary causes of 
hypertension was done by the respective treating physician. Thus though 9 subjects 
were found to have a secondary cause for the hypertension, this number would have 
been higher if all subjects had undergone a complete evaluation.  
Omura et al, in a prospective study among 1020 patients with hypertension carried out 
a two tiered evaluation for secondary causes of hypertension. The first tier involved 
testing for the plasma levels of renin, aldosterone, cortisol and catecholamines and an 
ultrasound of the abdomen. The second tier then consisted of a furosemide plus 
upright test, captopril renography, dexamethasone suppression test and a 24 hour 
urinary catecholamine estimation and a CT of the abdomen. With such testing they 
80 
 
were able to detect secondary causes of hypertension in 9.2% (after excluding renal 
causes). Of these 6% were due to primary aldosteronism (15).  
 
 
b) Secondary hypertension 
 
Of the 85 subjects included in this study, 9 were found to have a secondary underlying 
cause for the hypertension. Thus the prevalence of secondary hypertension in this 
cross sectional descriptive study is 11%. The commonest causes among these being 
renal and endocrine related. This is in keeping with other studies which have 
documented similar rates of secondary hypertension. Population studies have shown 
the prevalence of secondary hypertension to be lower and between 1.1% and 5.7% 
(52). In children rates of upto 85% have been documented and in adults between 5 to 
10% (53). 
c) Primary hypertension 
 
In those with Primary hypertension, the majority of subjects [72% (55)] were between 
the age groups of 31 and 40. Though of the total number, approximately half had an 
onset of hypertension before 30 years. This is in keeping with existing literature, 
where the prevalence of hypertension increases with increasing age (16,19).  
The gender distribution of hypertension in this study, found that there were more men 
than women with 64% (49) men and 36% (32) women. This difference could 
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represent either a true difference in the prevalence of essential hypertension between 
men and women or a difference in the health seeking behaviour between men and 
women.  
 
 
There was a positive family history of hypertension in 70% (53) of the subjects with 
primary hypertension as compared to 30% (23) who did not. This is in keeping with 
studies showing a positive family history for hypertension to be a non-modifiable risk 
factor for hypertension. A Population study from Karnataka, found a positive family 
history in 41% of individuals with hypertension (54).  
With regards to the nature of residence, 66% (50) were from an urban residence and 
34% (26) were from a rural residence. This again is in keeping with the prevalence of 
hypertension being higher in urban areas as compared to rural areas (8).  
 
The prevalence of diabetes mellitus was found to be 11% while that of dyslipidaemia 
was 39%. The prevalence of obesity was higher at 61%. With regards to obesity, 
central obesity as measured by waist circumference and waist-hip ratio and the 
percentage of body fat were also measured. Waist-hip ratio, is a better indicator of 
central obesity and cardiovascular risk as compared to the body mass index. Also the 
percentage of body fat is a better indicator of total body fat than the body mass index.  
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The relationship between body mass index and the percentage of body fat depends of 
factors such as age, sex and varies in ethnic populations.  
Numerous Indian studies have shown diabetes mellitus, dyslipidaemia and obesity to 
be a risk factors for hypertension (23) (55) (8).  
 
 
Stress:  
Among those with primary hypertension, there was an approximately equal 
distribution of those with low and high stress levels.  Also when comparing between 
various groups, such as men and women, obese and non-obese, rural and urban and 
those from Tamil Nadu and West Bengal / Bangladesh, there was no statistically 
significant difference between groups with regards to stress levels. The stress score 
used in this study is the Cohen perceived stress scale, which rates the perceived stress 
over the past month into low and high stress categories. The advantage of this scale is 
the ease in administration. Some of the difficulties that were encountered were those 
of language and difficulty with recall, as this rates the stress over the past month. Also 
most of the answers were subjective. Other existing stress scores like the Holmes and 
Rahe stress Inventory had a 43 item questionnaire which was too tedious to 
administer.  
As this stress scale rates the perceived stress over the past month, it is not a reflection 
of the stress levels of the individual at the time of diagnosis of hypertension. It also 
does not capture the periodic variations in stress levels that one may face.  
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What can be concluded though is that roughly half the number of subjects had high 
perceived levels of stress, which needs to be addressed as part of the treatment 
strategy.   
Physical activity:   
Of the 42 subjects who underwent a physical activity evaluation, 29% (12) had low 
levels of activity, 45% (19) had medium levels of activity and 26% 11) had high levels 
of activity. Thus most subjects had a low to medium level of activity. Studies 
measuring levels of physical activity in India are sparse. A study among a working 
adult population in Bangalore, found low levels of physical activity among both men 
and women (56). A study among residents in the city of Thiruvananthapuram, Kerala, 
found an inverse relationship between occupations involving moderate or greater 
physical activity with the prevalence of hypertension (57). 
As the subjects, in this study had low to medium levels of physical activity, this is a 
modifiable risk factor which needs to be addressed. Increasing physical activity should 
be part of the management of blood pressure control in this population.  
 
Dietary factors:  
As per the DASH diet, the two most important dietary modifications for hypertensive 
patients is a diet that is low in salt and high in potassium (fruit and vegetables). This 
study found a high prevalence of extra dietary salt being added to food. Indian studies 
addressing dietary salt intake have documented amounts ranging from 8.5 grams per 
day to 42.3 grams per day by using methods such as household salt weighing, food 
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frequency questionnaire and 24 hour urinary sodium excretion. This is variation may 
be due to the different dietary practices in different regions of the country (45). The 
DASH diet recommends a dietary salt intake of 2.3 grams of salt per day. 
 The DASH diet recommends 8 to 10 servings of fruit and vegetables per day, which 
was not consumed by any of the subjects. The maximum number of servings of fruit 
and vegetables that were consumed were three per day and this too in 45% of subjects.  
End organ damage:   
Evidence of end organ damage was assessed by electrocardiographic (ECG) evidence 
of left ventricular hypertrophy (LVH). One of the drawbacks of the same is that the 
ECG has a low sensitivity but a high specificity, compared to the echocardiogram 
which is the gold standard for detecting LVH. Studies from the Framingham Heart 
Study have shown a sensitivity of 6.9 % and a specificity of 98.8% (58). A study from 
South India looking at ECG for the diagnosis of left ventricular hypertrophy found the 
sensitivity to be 43.5% and the specificity to be 88.9%. Thus, though the 
electrocardiogram is not the ideal screening tool for LVH, it is easily available and 
cheaper.  
Of the 76 subjects with primary hypertension, only 54 underwent an 
electrocardiogram. The number of subjects with LVH was 20 (37%). This is to say 
that a little over a third of the subjects had evidence of end organ damage at the time 
of this study.  
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Studies from other parts of the country have shown the prevalence of LVH among 
those with hypertension to vary, with prevalence ranging from 6.5% (Mizoram), 4.4% 
(Assam),  22.1% (Mumbai) and 21% ( Tea garden workers of Assam) (59) (60).  
The higher prevalence of LVH in this study could be due to other coexisting factors 
like obesity and dyslipidaemia which could also be contributing to the same. Increased 
physical activity is unlikely to be a cause as the assessment for physical activity 
showed a higher proportion of low to moderate physical activity.  
Given the young age of this study population, this brings into sharp focus the need for 
earlier detection of hypertension and adequate control of the same with simultaneous 
management of the modifiable risk factors.  
Control of blood pressure:  
Of the 76 patients with primary hypertension, 21 patients were not on any 
antihypertensive medications. Of the remaining, the majority were using either a 
calcium channel blocker or an ACE/ARB for the control of blood pressure. This is in 
keeping with current recommendations regarding antihypertensive medication use in 
this population. With regard to the control of blood pressure, it was found that the 
blood pressure was only well controlled in 40% of subjects. This could be attributed to 
many factors. Some of the subjects had been incidentally diagnosed just prior to 
recruitment to the study and had not yet been initiated on antihypertensive therapy. 
Also this study did not look into the dosing of antihypertensive medications to assess 
adequacy. A systematic review and meta-analysis of blood pressure control in India, 
found varying rates of control in different regions of the country. Among rural 
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populations, the control of blood pressure was 10.7% (6.5-15%) and in urban 
populations it was 20.2% (11.6-28.7) (61). A cross-sectional survey from 
Thiruvananthapuram, Kerala, found adequate blood pressure control in 30.6% of 
antihypertensive patients (57). The PURE study – The Prospective Urban Rural 
Epidemiology study found the control of blood pressure to be 13% on average 
between the countries of India, Pakistan and Bangladesh (62).  
The difference in rates of blood pressure control between these studies and the current 
study could be due to the fact that these are epidemiological studies that were 
community and not clinic based.  
Tamil Nadu Vs West Bengal / Bangladesh: 
On comparing the differences between those from Tamil Nadu and West Bengal / 
Bangladesh, the following were found: 
With regard to the age of the subjects, it was found that in the age group of 18 – 30, 
the number of subjects from West Bengal / Bangladesh [33% (9)], was twice that of 
those from Tamil Nadu [15% (4)], with a trend to significance.  
There was a statistically significant difference in the age of onset, with the subjects 
from Tamil Nadu, having an older age of onset [69% (17)] as compared to those from 
West Bengal / Bangladesh [37% (10)]. This could represent a difference in the health 
seeking behaviour between the two regions or a difference due to the referral bias. It 
could also be due to the actual difference in the age of onset of primary hypertension 
in both these regions due to genetic factors. This raises the question if genotypic 
differences could have resulted in this phenotypic difference.   
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Another reason for this difference could be that of earlier detection in the states of 
West Bengal / Bangladesh. The health Indices of Tamil Nadu fare better than those of 
West Bengal / Bangladesh, and given that a majority of subjects were asymptomatic, 
better surveillance in West Bengal/ Bangladesh seems unlikely. The cause of this 
difference requires further study. 
A difference in the risk factors associated with hypertension showed a statistically 
significant difference between the two groups with respect to diabetes mellitus and 
trend to significant with respect to dyslipidaemia and alcohol use.  
Diabetes mellitus: The prevalence of diabetes mellitus was 15% (4) among those from 
West Bengal / Bangladesh as compared to 0% from Tamil Nadu. Though statistically 
significant, it is difficult to give much weightage to this difference due to the small 
number. 
Dyslipidaemia and obesity: The prevalence of dyslipidaemia in the subjects from 
West Bengal / Bangladesh was 56% (13) in comparison to those from Tamil Nadu 
31% (8). When looking at obesity though the prevalence between both groups was 
similar, with 58% (15) from Tamil Nadu and 60% (16) being obese.  
The reason for the lower prevalence of dyslipidaemia among those from Tamil Nadu 
could be attributed to genetic factors and dietary habits. The prevalence of 
dyslipidaemia did not take into account treatment for the same and hence treatment of 
dyslipidaemia cannot contribute to the difference found between these two groups. 
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Men vs women: 
With respect to the risk factors of hypertension, there was a difference in the risk 
factors of residence, family history of hypertension and diabetes mellitus, with a trend 
to significance. There was a statistically significant difference between the two groups 
with respect to alcohol use and obesity. The difference in alcohol use is not surprising, 
as alcohol consumption among women in India is low.  
The incidence of obesity among men was 66% (30) as compared to 35% (11) in 
women and was statistically significant.  The difference in central obesity though was 
not statistically significant. This could be attributed to the metabolic syndrome which 
is associated with hypertension.   
 
Obese Vs Non obese:  
 With regard to the age of the subjects, there was a statistically significant difference 
between those with and without obesity. Among those with obesity, [85% (40)] were 
older than 30 years as compared to only [52% (15)] of those without obesity. In those 
without obesity, the age distribution between those less than 30 [48% (14)] and more 
than 30 [52% (15)] was roughly the same.  
Among those with obesity, a significantly larger number, [64% (30)] developed 
hypertension before the age of 30, as compared to those without obesity [41% (12)]. 
This finding supports the fact that obesity is a risk factor for essential hypertension.  
Rural vs urban residence:  
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On comparing subjects from Rural and urban residences, the following differences 
were found: 
The only statistically significantly risk factor for hypertension between those from 
rural and urban residences was a family history of hypertension. Among those from an 
urban residence, the prevalence of hypertension was 78% (38), as compared to 54% 
(14) living in a rural area. This is similar to a study from Karnataka, comparing the 
prevalence of hypertension between rural and urban populations between the ages of 
20 and 40 in 991 individuals. A family history of hypertension was found more among 
those from an urban residence as compared to a rural residence. Among those with 
hypertension, a family history of hypertension was found in 68.8% or urban residents 
as compared to 20.69% of rural residents (24).  
The cause for essential hypertension is a combination of genetic and environmental 
factors. And thus, people with a genetic predisposition to hypertension, with added 
environmental factors, in this case urban residence, could go on to develop 
hypertension.  
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Conclusion: 
 
1. This study found the prevalence of secondary causes of hypertension in the age 
group of 18 – 40, in this tertiary care hospital to be 10%.  
2. A majority of subjects were incidentally detected to have hypertension. 
3. Non- modifiable risk factors that were associated with hypertension were Age, 
gender, residence and a family history of hypertension. 
4. The modifiable risk factors that were associated with hypertension were Obesity, 
low physical activity and added dietary salt.  
5. There was a regional difference between the age of onset between those from Tamil 
Nadu and West Bengal / Bangladesh.  
6. The prevalence of Obesity, as defined by body mass index was higher among men 
than women though central obesity was high among both men and women.  
7. A positive family history of hypertension was higher among those from an urban 
residence as compared to a rural residence.  
8. A majority of subjects had uncontrolled blood pressures. 
9. There was a predominance of urban residents in this study with hypertension. 
10. Roughly half the subjects had high levels of perceived stress. 
11. Most of the subjects had low levels of physical activity. 
12. Obesity, which is a risk factor for hypertension, was seen more among the older 
age group. 
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Limitations: 
 
1. The estimated sample size was 168, but only 85 was reached. Thus, this may not be 
fully representative of young hypertensive patients attending the General Medicine 
OPD at CMCH. 
2. The distribution of subjects who had a full evaluation for secondary cause of 
hypertension, dietary and physical activity evaluation was not complete. Thus some 
patients with secondary hypertension could have been missed out because they were 
not fully evaluated. 
3. Patients were not routinely evaluated for primary aldosteronism, which in this age 
group is the leading cause of secondary hypertension. 
4. The stress questionnaire that was used was the Cohen perceived stress 
questionnaire. This assesses perceived stress in the preceding month. Thus, this may 
not actually be representative of the actual stress. 
5. Though there were statistically significant differences between the groups studied, 
this study was not powered to detect these differences.   
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Recommendations: 
1.  An important public health initiative would be screening individuals over the age 
of 18, for hypertension periodically.  
2. This study has also shown that a number of modifiable risk factors are associated 
with primary hypertension, and hence these should be addressed to achieve better 
blood pressure control.  
3. Dietary modifications as per the DASH diet, increased physical activity and stress 
relieving techniques should be encouraged in all hypertensive patients.  
4. The department of Medicine should formulate a protocol to evaluate all patients 
below the age of 40 years for secondary causes of hypertension. 
5. As Primary aldosteronism is the commonest cause of hypertension in middle-aged 
adults, patients in this age group with hypertension should routinely be evaluated for 
the same with a renin: aldosterone ratio and serum potassium used as a screening tool. 
6. Hypertensive patients should be screened for obstructive sleep apnoea.  
7. Further studies are required to study the differences between the modifiable risk 
factors among hypertensive individuals less than 40 years old and older. 
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Annexures: 
 
 
 
 
 
 
 
PATIENT INFORMATION AND INFORMED CONSENT: 
Purpose and subject information and consent form 
We are conducting a study on patients presenting with hypertension at a 
young age and would like to invite you to be a part of this study.  
This form describes what this study is about and how it will be carried out. 
Signing this form will mean that you have agreed to take part. Please read this 
form carefully and clarify any doubts that you may have regarding the study. 
Feel free to discuss this with your family or friends. Your participation in this 
study is a voluntary act and you are free to refuse participation. Your refusal to 
participate in this study will in no way affect your ongoing medical care and 
treatment in CMCH. 
 Purpose of this study 
This study is being carried out to study in detail patients presenting with 
hypertension at a young age. By doing so we will be able to understand the 
profile of such patients who present to us.  
By agreeing to take part, what will you have to do? 
On agreeing to participate, 25 minutes of your time will be used to ask a few 
questions regarding your history and conduct an examination. Your laboratory 
investigations will be reviewed 
Other treatments that you are already on will be continued and your regular 
treatment will not be changed during this study.  
Potential risks and discomforts.  
This study does not involve any new drug or treatment. There are no other 
potential discomforts from this study. 
Potential benefits. 
By participating in this study you will help us understand the profile of young 
onset hypertension better. This will then enable us to formulate a more 
efficient protocol for investigating patients like yourself. 
 
Voluntary participation and withdrawal 
Participation in this study is entirely voluntary and you may choose not to 
participate. Doing so will not affect your medical care in CMCH in any way. 
 
 Study related injury 
We do not expect any injury to happen to you be participating in this study. 
Payment for the study  
All your investigations will be done at the cost decided by your treating 
physician.  
Confidentiality 
The results of this study will be published in a medical journal but you will not 
be identified by name in any publication or presentation of results. However, 
your medical notes will be reviewed by people associated with the study, 
without your additional permission, should you decide to participate in this 
study.  
Legal rights  
You are not waiving any of your legal rights by participating in this study or by 
signing this consent form, for example, the right to seek damages under law 
for any research related injury. 
CONSENT TO TAKE PART IN THIS CLINICAL TRIAL 
Study Title: Profile of patients with young onset hypertension at a Tertiary care 
hospital in South India. 
Study Number: 
Participant’s name:  
Date of Birth / Age (in years): 
 
I_____________________________________________________________ 
___________, son/daughter of  ___________________________________ 
1  have read and understood the information sheet provided to me about this 
and have clarified any doubts that I had.  
2. I understand that participation in this study is entirely voluntary. It in not 
way affects my medical care in CMC nor does it infringe on my legal rights. 
 3. I understand that there are no financial benefits from participating in this 
study. 
4. By consenting to participate in this study, I understand that the study staff 
and institutional ethics committee members will not need my permission to 
look at my health records. I agree to this access.   
5. I understand that my identity will not be revealed in any information 
released to third parties or published.   
 
I voluntarily agree to take part in this study 
Name: 
Signature: 
Date: 
Name of witness: 
Relation to participant: 
Date: 
 
 
 
 
Food frequency questionnaire: 
 
  
10.Added salt ( teaspoon per day): 
 
 
 
 
 
 
 
 Food type ≤ once 
a 
month 
1 -3 
/month 
1 per 
week 
2 – 4 
per 
week 
5 – 6 
per 
week 
1 per 
day 
2 – 3 
per 
day 
 
1 Red meat         
2 Fish         
3 Fruit/Veg( 1 
serving)  
        
4 Saturated 
fat(Butter/ghee) 
        
5 Alcohol(60 gms)         
6 Fast food         
7 Soft drinks         
8 Sweets         
9 Eating out         
STOP  BANG Questionnaire 
 
Height _____ inches/cm Weight _____ lb/kg 
Age _____  
Male/Female  
BMI _____ 
Collar size of shirt: S, M, L, XL, or _____ inches/cm 
Neck circumference* _____ cm 
 
1. Snoring 
Do you snore loudly (louder than talking or loud enough to be heard 
through closed doors)? 
Yes   No 
 
2. Tired 
Do you often feel tired, fatigued, or sleepy during daytime? 
Yes   No 
 
3. Observed 
Has anyone observed you stop breathing during your sleep? 
Yes   No 
 
4. Blood pressure 
Do you have or are you being treated for high blood pressure? 
Yes   No 
 
5. BMI 
BMI more than 35 kg/m2? 
Yes   No 
 
6. Age 
Age over 50 yr old? 
Yes   No 
 
7. Neck circumference 
Neck circumference greater than 40 cm? 
Yes   No 
 
8. Gender 
Gender male? 
Yes   No 
 
* Neck circumference is measured by staff 
 
High risk of OSA: answering yes to three or more items 
Low risk of OSA: answering yes to less than three items 
 
Adapted from: 
STOP Questionnaire 
A Tool to Screen Patients for Obstructive Sleep Apnea 
Frances Chung, F.R.C.P.C.,* Balaji Yegneswaran, M.B.B.S.,† Pu Liao, M.D.,‡ Sharon A. Chung, Ph.D.,§ 
Santhira Vairavanathan, M.B.B.S.,_ Sazzadul Islam, M.Sc.,_ Ali Khajehdehi, M.D.,† Colin M. Shapiro, F.R.C.P.C.# 
Anesthesiology 2008; 108:812–21 Copyright © 2008, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. 
COHEN PERCEIVED STRESS 
 
 
The following questions ask about your feelings and thoughts during THE 
PAST MONTH.   In each question, you will be asked HOW OFTEN you felt or 
thought a certain way. Although some of the questions are similar, there are 
small differences between them and you should treat each one as a separate 
question. The best approach is to answer fairly quickly. That is, don t try to 
count up the exact number of times you felt a particular way, but tell me the 
answer that in general seems the best. 
 
For each statement, please tell me if you have had these thoughts or feelings:  never, 
almost never, sometimes, fairly often, or very often. (Read all answer choices each time) 
 
 Never Almost 
Never 
Sometimes Fairly 
Often 
Very 
Often 
B.1. In the past month, how often 
have you been upset because of 
something that happened 
unexpectedly?  
0 1 2 3 4 
B.2. In the past month, how often 
have you felt unable to control the 
important things in your life? 
0 1 2 3 4 
B.3. In the past month, how often 
have you felt nervous or stressed? 
0 1 2 3 4 
B.4. In the past month, how often 
have you felt confident about your 
ability to handle personal 
problems? 
0 1 2 3 4 
B.5. In the past month, how often 
have you felt that things were going 
your way? 
0 1 2 3 4 
B.6. In the past month, how often 
have you found that you could not 
cope with all the things you had to 
do? 
0 1 2 3 4 
B.7. In the past month, how often 
have you been able to control 
irritations in your life? 
0 1 2 3 4 
B.8. In the past month, how often 
have you felt that you were on top 
of things? 
0 1 2 3 4 
B.9. In the past month, how often 
have you been angry because of 
things that happened that were 
outside of your control? 
0 1 2 3 4 
B.10. In the past month, how often 
have you felt that difficulties were 
piling up so high that you could not 
overcome them? 
0 1 2 3 4 
 
 
 
Perceived Stress Scale Scoring  
Each item is rated on a 5-point scale ranging from never (0) to almost always (4). 
Positively worded items are reverse scored, and the ratings are summed, with 
higher scores indicating more perceived stress. 
 
PSS-10 scores are obtained by reversing the scores on the four positive items: 
For example, 0=4, 1=3, 2=2, etc. and then summing across all 10 items.   
Items 4, 5, 7, and 8 are the positively stated items.  
 
 
Your Perceived Stress Level was ________ 
 
Scores around 13 are considered average.  In our own research, we have found that high stress 
groups usually have a stress score of around 20 points.  Scores of 20 or higher are considered 
high stress, and if you are in this range, you might consider learning new stress reduction 
techniques as well as increasing your exercise to at least three times a week.  High psychological 
stress is associated with high blood pressure, higher BMI, larger waist to hip ratio, shorter 
telomere length, higher cortisol levels, suppressed immune function, decreased sleep, and 
increased alcohol consumption. These are all important risk factors for cardiovascular disease.  
 
 
 
 
 
id ho na age sex state resid agos dura sysbp diabp prese cns dm dl famht famd famdl famihfamcv famckfamobrx antiht other tobactypto pack alcohalcwh typal amoun
1 24976veena de 38 1 5 1 35 72 999 999 1 1 0 0 0 0 0 0 0 0 0 1 2 0 0 0
2 25143hemanta 39 0 28 0 36 72 160 90 5 0 1 0 0 0 0 0 0 0 1 1 0 0 0
3 23027suresh 38 0 28 1 38 6 150 95 5 0 0 1 0 0 0 0 0 0 1 4 0 0 0
4 21718Subbala 31 1 1 0 31 6 170 999 1 2 1 0 0 0 0 0 0 0 0 1 2 0 0 0
5 17763buddhi 36 0 33 1 28 96 140 90 1 1 1 0 1 0 0 0 0 0 0 1 2 0 0 0
6 16795sam pau 23 0 11 1 21 24 140 100 5 0 0 1 1 0 0 0 0 0 1 2 0 0 0
7 82303babu R 33 0 24 1 32 12 160 110 1 2 0 0 1 0 0 0 0 0 0 1 2 0 0 0
8 17163joynul 26 0 33 1 26 0 999 999 5 0 0 0 1 0 0 0 0 0 0 0 0 0
9 17939rojeet 27 0 3 1 27 6 140 90 5 0 0 1 0 0 0 0 0 0 0 0 0 1 1 3 180
10 17305akhanda 27 0 20 1 20 84 140 90 5 0 1 1 1 0 0 0 0 0 1 1 0 0 0
11 06375nirmala 19 1 1 0 18 24 160 130 1 3 0 0 0 0 0 0 0 0 0 1 2 0 0 0
12 49678suresh 32 0 32 1 32 1 210 140 5 0 0 1 1 0 0 0 0 0 0 0 0 0
13 14573amit bar 35 1 5 1 34 12 140 100 5 1 0 1 1 0 0 0 0 0 1 2 0 1 1 1 1 2 3 180
14 11238shyamal 28 0 28 0 28 1 150 110 1 2 0 0 1 0 0 0 0 0 0 0 0 1 2 2.5 0
15 12388joyder p 36 0 28 1 28 96 140 100 1 2 0 0 1 0 0 0 1 0 0 1 2 0 1 1 13.5 1 2
16 13314kavitha 38 1 24 1 30 96 999 999 5 0 0 0 1 0 1 0 0 1 1 2 0 0 0
17 64499madhu b 37 0 24 1 36 12 999 999 5 0 0 0 0 0 0 0 0 0 0 0 1 1 1.5 1 1 1 60
18 01079rathna 38 1 24 1 36 8 160 110 5 0 0 0 0 0 0 0 0 0 1 2 0 0 0
19 33399rani 32 1 1 0 32 2 140 90 5 0 0 0 0 0 0 0 0 0 0 0 0 0
20 16723amita ch 36 1 28 0 36 6 160 130 5 0 0 0 0 0 0 0 0 0 0 1 0 0
21 16653sathees 33 0 24 1 33 1 999 999 5 0 0 0 0 0 0 0 0 0 1 2 0 0 0
22 16411dinakara 26 0 24 0 24 24 999 999 1 2 0 0 1 1 0 0 0 0 0 1 2 0 0 0
23 16634thilagan 37 0 24 0 37 1 150 999 1 2 0 1 0 0 0 0 0 0 0 0 0 0 1 1 3 60
24 84676soumya 29 1 28 1 27 24 160 100 5 0 0 1 0 1 0 0 0 1 1 2 0 0 0
25 93918kavitha 33 1 24 1 28 60 140 110 2 0 0 1 0 0 0 0 0 0 1 2 0 0 0
26 93233kalaiche 33 0 24 0 33 1 220 150 5 0 0 1 1 0 0 0 0 0 1 1 0 0 0
27 14862nerthika 31 1 24 1 31 0 160 110 5 0 0 1 1 0 0 0 0 1 1 2 0 0 0
28 89350sunitha 38 1 24 1 36 24 160 100 5 0 1 1 1 0 1 0 0 0 1 1 1 0 0
29 14037khusen d 36 1 23 0 35 48 140 90 1 2 0 0 1 0 0 0 0 0 0 0 0 0 0
30 13790subimal 39 0 5 1 32 84 140 90 5 1 1 1 0 0 0 0 0 0 1 1 0 0 0
31 60330tapasi b 36 1 3 1 32 48 150 110 5 0 0 1 0 0 0 0 0 0 0 0 0 0
32 93961rishabh 21 0 26 1 21 1 170 92 5 0 0 1 0 0 0 0 0 0 0 0 1 1 1 1 1 3 60
33 14872elumalai 37 0 24 1 37 12 140 90 5 0 1 1 1 0 0 0 0 0 1 1 0 0 0
34 94720bahadur 35 0 23 0 38 2 170 120 5 0 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 4 60
35 16399nilonjon 30 0 33 0 28 24 160 130 1 1 0 0 1 0 0 0 0 0 0 1 1 0 0 0
36 14528pinki si 32 1 5 1 30 24 140 120 1 2 0 0 1 1 0 0 0 0 0 1 3 0 0 0
37 74909velu k 32 0 24 0 30 24 999 999 1 1 1 0 1 1 0 0 0 0 0 1 1 0 0 0
38 72563senthil 37 0 24 1 37 1 160 100 5 0 0 1 1 0 0 0 0 0 1 1 0 0 0
39 20389aklima 34 1 33 0 31 36 180 90 5 0 0 1 0 0 0 0 0 0 1 2 0 0 0
40 24138arnab m 21 0 28 1 18 72 160 90 5 0 0 1 0 0 0 0 0 0 1 1 0 0 0
41 24301nilima 24 1 33 1 21 36 999 999 5 0 0 1 0 0 0 0 1 0 0 0 0 0
42 24678deepak 40 0 3 1 40 3 210 170 1 1 0 0 1 0 0 0 0 0 0 1 2 0 0 1 2 1 60
43 95940ganesh 35 0 24 1 33 24 180 120 5 0 0 1 1 1 0 0 0 0 0 0 1 1 7 1 1 3 60
44 24218zaman 35 0 33 1 28 84 140 90 5 0 0 1 0 0 0 1 0 0 1 1 0 1 1 5 0
45 23677mohamm 35 0 33 0 33 24 999 999 5 0 0 1 0 0 0 0 0 0 1 2 0 0 0
46 15572mahesh 19 0 24 1 19 2 140 90 5 0 0 1 0 0 0 0 0 0 0 0 0 0
47 99850sathish 31 0 24 1 27 48 180 999 1 2 0 0 1 0 0 0 0 0 0 1 1 0 0 0
48 22315sanjay 33 0 5 1 32 12 170 90 5 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 60
49 09314alamelu 37 1 24 0 37 2 190 120 1 2 0 1 1 0 0 0 0 0 0 1 2 0 0 0
50 21565kun kun 39 1 28 1 35 48 999 999 5 1 1 1 0 0 1 0 0 0 1 1 0 1 0 0
51 20755shahina 38 1 33 0 38 0 999 999 5 1 0 1 1 0 1 0 0 0 0 0 0 0
52 23982srinivas 34 0 24 1 34 1 160 100 2 0 0 0 1 0 1 0 0 0 1 2 0 1 1 1 1 1 3 120
53 23118rupanjita 26 1 25 1 22 48 999 999 1 2 1 0 1 1 0 0 0 0 0 1 1 0 0 0
54 22776ashutosh 38 0 4 1 36 24 140 100 5 0 0 1 1 0 1 0 0 0 1 1 0 0 0
55 23084biswajith 36 0 28 1 28 96 150 96 5 0 1 1 1 0 0 0 0 0 0 0 0 0
56 23083tagari s 30 1 28 0 30 0 150 90 5 0 0 0 0 0 0 0 0 0 0 1 0 0
57 21701suji priy 32 1 24 1 30 24 180 120 5 0 0 0 0 0 0 0 0 0 0 0 0 0
58 50480rajesh k 39 0 5 1 38 12 140 100 5 0 0 1 0 0 0 0 0 0 1 1 0 0 0
59 18013manoj g 35 0 12 1 35 5 160 100 5 0 0 1 1 0 0 0 0 0 1 0 0 1 1 3 60
60 18631tridip da 38 0 28 1 38 0 160 100 5 0 0 1 0 0 1 0 0 1 0 0 1 1 7 0
61 18517supriya 31 1 28 0 30 12 180 100 1 3 0 1 0 0 0 0 0 0 0 1 3 0 0 0
62 60884arnab ma 30 0 28 1 29 10 160 100 1 1 0 1 1 0 0 1 0 0 0 1 2 0 0 0
63 94600chenchu 30 0 1 0 30 2 220 100 5 0 0 0 1 0 1 0 0 0 1 2 0 0 0
64 92539faritha 22 1 28 1 22 4 170 90 5 0 0 1 0 0 0 0 0 0 1 1 0 0 0
65 16614shantha 35 0 28 1 28 84 240 999 1 3 0 0 1 0 0 0 0 0 0 1 1 0 0 0
66 81386rahul ro 37 0 25 1 34 36 999 999 1 1 0 1 0 1 0 0 0 0 0 1 3 0 1 1 4 1 1 3 60
67 93134gokula k 20 0 24 1 20 4 160 100 1 1 0 0 0 0 0 0 0 0 0 1 2 0 0 0
68 18656jayagun 34 1 3 0 31 36 999 999 5 0 0 0 0 0 0 0 0 0 1 1 0 0 0
69 14516maniara 40 0 24 0 31 108 140 100 5 0 1 1 0 0 0 0 0 0 1 1 0 0 0
70 18017rajkumar 36 0 33 0 34 24 150 100 1 1 0 1 1 1 0 0 0 0 0 1 3 0 0 0
71 86602samson 37 0 24 1 37 4 160 100 5 0 1 1 1 1 0 0 0 1 1 2 0 0 0
72 11023kumar h 38 0 24 1 38 3 230 999 1 3 0 1 1 0 0 0 0 0 0 1 1 0 0 1 2 3 120
73 40270sultana 39 1 24 1 37 24 170 100 5 0 0 1 0 0 0 0 0 0 1 2 0 0 0
74 13016ifthekha 32 0 33 1 28 48 140 100 1 1 0 1 1 1 0 0 0 0 0 0 0 0 0
75 13587Anish J 24 0 4 1 22 24 170 100 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0
76 13266sangeet 35 1 24 1 35 0 160 120 5 0 1 1 0 0 0 0 0 0 0 2 0 0
77 12547sahana 36 1 4 0 36 1 150 100 5 1 1 0 0 0 0 0 0 0 1 1 2 0 0
78 13539sushanta 38 0 28 0 38 0 180 100 5 1 0 1 0 0 0 0 0 0 0 0 0 0
79 58383gobinda 25 0 28 1 25 0 158 96 5 0 0 0 0 0 0 0 0 0 0 0 0 0
80 61377satish k 36 0 24 1 36 4 180 120 5 0 0 1 1 0 0 0 0 0 1 1 0 0 0
81 13307mahabu 37 1 33 0 28 96 999 999 1 1 0 1 1 0 1 1 0 0 0 1 1 0 0 0
82 18716kenneth 34 0 24 1 34 6 200 999 5 0 1 1 0 1 0 0 0 0 1 2 0 0 1 1 3 120
83 40345anjala 28 1 24 0 28 0 200 100 1 3 0 0 1 1 0 1 0 0 0 0 0 0 0
84 19544manjula 36 1 24 0 36 6 180 140 1 1 0 0 0 1 0 0 0 0 0 1 2 0 0 0
85 24598muthupa 29 0 24 0 27 24 150 90 1 1 0 0 0 1 0 0 0 0 0 1 2 0 1 1 5 0
freqarenacushphe hyperthypot osa systbp diastb heighweight waist hip acansighy sighypsigcu renal pulsescreapotasscholestrigly hdl ldl ac pc tsh cortisol uricas urimet
0 0 0 0 0 0 150 80 150 64 101 94 0 0 0 0 0 0 0.6 4.1 225 178 48 159 5.7 0 487
0 0 0 0 0 0 166 67 89 93 0 0 0 0 0 0 0.9 3.5 138 142 26 93 136 140 0.1 19.1 0
0 0 0 0 0 0 165 67 94 95 0 0 0 0 0 0 0.8 159 361 31 81 127 129 3.9 0 153
0 0 0 0 0 0 0 0 0 0 0 0 0.7 4.3 191 160 37 130 115 184 99.9 0
0 0 0 0 0 0 999 999 175 72 91 98 0 0 0 0 0 0 1 4.1 185 373 25 101 134 221 1.3 16.3 0
0 0 0 0 0 0 999 999 172 58 73 93 0 0 0 0 0 0 0.9 4.2 148 91 2.1 13.1 0
0 0 0 0 0 0 160 100 161 57 83 93 0 0 0 0 0 0 0.8 1.4 15.6 0 170
0 0 0 0 0 0 999 999 162 77 91 100 1 0 0 0 0 0 0.8 4.6 218 474 33 137 101 125 1.7 0
3 0 0 0 0 0 0 999 999 175 70 86 101 0 0 0 0 0 0 1 4.4 166 79 46 102 89 93 1.3 21.8 0 224
0 0 0 0 0 0 0 0 0 0 0 0 0.8 4.1 105 160 40 80 89 122 0.9 23.1 0 100
0 0 0 0 0 0 999 999 160 48 71 88 0 0 0 0 0 0 0.9 4.1 0 124
0 0 0 0 0 1 999 999 165 87 100 109 0 0 0 0 0 0 0.9 169 104 36 113 90 82 4.8 13 1 517
4 0 0 0 0 0 0 999 999 999 999 999 999 0 0 0 0 0 0 0.7 4.7 93 1 22 0 272
0 0 0 0 0 0 150 110 163 46 70 82 0 0 0 0 0 0 0.8 3.5 201 104 37 145 2.8 0 180
0 0 0 0 0 0 999 999 999 999 999 999 0 0 0 0 0 0 0.9 201 196 31 144 88 124 1.9 0 253
0 0 0 0 0 0 999 999 999 70 97 107 0 0 0 0 0 0 6.4 0 226
3 0 0 0 0 0 0 130 80 999 92 102 108 0 0 0 0 0 0 0.9 4.3 166 174 32 110 94 70 0 446
0 0 0 0 0 0 999 999 154 65 88 106 1 0 0 0 0 0 0.7 4.1 136 101 45 80 96 130 0.9 11.2 0
0 0 0 0 0 0 999 999 167 74 98 96 0 0 0 0 0 0 0.8 3.8 90 2.1 9.3 0
0 0 0 0 0 0 999 999 162 60 999 999 0 0 0 0 0 0 0
0 0 0 0 0 0 999 999 168 69 88 97 0 0 0 0 0 0 0.9 3.9 2.9 0 460
0 0 0 0 0 0 999 999 184 83 90 98 0 0 0 0 0 0 0.9 4.2 154 98 37 104 88 83 1.5 0 220
2 0 0 0 0 0 0 999 999 161 68 96 96 0 0 0 0 0 0 0.7 3.7 127 97 167 0
0 0 0 0 0 1 120 80 184 96 94 107 0 0 0 0 0 0 0.9 3.7 188 104 34 134 92 91 2.2 22.7 0 389
0 0 0 0 0 0 999 999 159 999 77 117 0 0 0 0 0 0 0.5 4 139 72 45 91 86 80 1.9 14.6 0 390
0 0 0 0 0 0 150 100 176 66 78 94 0 0 0 0 0 0 1 3.3 167 75 48 102 110 124 5.5 0 452
0 0 0 0 0 0 180 120 152 61 93 100 0 0 0 0 0 0 0
0 0 1 0 0 0 999 999 157 54 73 98 0 0 0 0 0 0 0.6 3.9 205 90 34 145 85 119 1.4 16.7 0 209
0 0 0 0 0 0 142 90 999 64 88 98 0 0 0 0 0 0 0.5 3.9 172 123 44 112 90 102 1.6 6.7 0 346
0 0 0 0 0 0 160 100 176 73 93 98 0 0 0 0 0 0 0.9 4.2 104 124 45 80 167 214 2.5 0
0 0 0 0 0 0 156 88 165 61 82 99 0 0 0 0 0 0 0.7 4 0
4 0 0 0 0 0 0 999 999 177 63 79 82 0 0 0 0 0 0 0.8 3.6 0
0 0 0 0 0 0 999 999 173 81 999 999 0 0 0 0 0 0 0.9 243 114 51 173 91 95 0.9 7.3 0 494
2 0 0 0 0 0 0 999 999 172 74 92 100 0 0 0 0 0 0 0.8 3.9 177 151 37 117 92 77 1.6 13.2 0 204
0 0 0 0 0 0 999 999 172 57 84 91 0 0 0 0 0 0 0.7 117 250 41 80 98 99 1.1 0 247
0 0 0 0 0 0 999 999 158 71 86 105 0 0 0 0 0 0 0.7 3.9 77 81 91 0
0 0 0 0 0 1 999 999 154 84 106 109 1 0 0 0 0 0 0.9 4.8 109 122 227 2.1 9.7 0
0 0 0 0 0 0 999 999 999 999 120 124 1 0 0 0 0 0 1 181 176 31 122 123 230 1.1 0
0 0 0 0 0 0 999 999 155 71 98 107 0 0 0 0 0 0 0.7 172 96 42 123 98 87 1.1 0 306
0 0 0 0 0 0 999 999 177 78 91 101 0 0 0 0 0 0 0.7 100 83 30 80 1.9 0 175
0 0 0 0 0 0 999 999 160 46 63 85 0 0 0 0 0 0 6 4 0
1 0 0 0 0 0 0 999 999 170 52 68 85 0 0 0 0 0 0 8.2 4.3 134 93 62 80 10.1 18.1 0 320
1 0 0 0 0 0 0 999 999 175 65 78 93 0 0 0 0 0 0 3.7 3.7 189 138 45 125 92 95 1.9 20.1 0 323
0 0 0 0 0 0 999 999 170 87 101 111 0 0 0 0 0 0 1 3.7 165 77 41 111 93 78 1.5 0 193
0 0 0 0 0 0 999 999 173 75 96 105 1 0 0 0 0 0 0.9 3.8 1.6 16.3 0
0 0 0 0 0 0 999 999 183 52 85 102 0 0 0 0 0 0 0.6 4.4 123 45 40 80 1.7 15.6 0 235
0 0 0 0 0 0 999 999 180 82 96 105 0 0 0 0 0 0 0.8 101 93 0
3 0 0 0 0 0 0 999 999 164 54 84 89 0 0 0 0 0 0 0.6 3.9 2.5 9.4 0 236
0 0 0 0 0 0 999 999 147 62 103 100 0 0 0 0 0 0 0.6 4.9 239 151 50 158 79 74 4.9 10.6 0 499
0 0 0 0 0 0 999 999 150 70 109 101 0 0 0 0 0 0 0.7 3.7 182 114 40 110 130 221 1.9 0
0 0 0 0 0 0 999 999 164 87 117 112 1 0 0 0 0 0 0.5 196 183 32 133 132 192 4.4 0 258
2 0 0 1 0 0 0 999 999 172 81 97 99 0 0 0 0 0 0 0
0 0 0 0 0 0 999 999 140 52 83 93 0 0 0 0 0 0 0.5 4.1 132 258 37 80 126 190 2.5 0 194
0 0 0 0 0 1 999 999 172 87 104 104 1 0 0 0 0 0 0.7 113 252 27 80 94 112 3.7 0 443
0 0 0 0 0 0 999 999 172 80 94 102 0 0 0 0 0 0 0.8 232 368 39 155 100 99 0 531
0 0 0 0 0 0 999 999 145 55 90 99 0 0 0 0 0 0 0.5 0
0 0 0 0 0 0 999 999 152 52 77 95 0 0 0 0 0 0 0.6 4.1 170 149 34 112 91 111 2.5 0 100
0 0 0 0 0 0 999 999 172 86 110 102 0 0 0 0 0 0 0.7 4 163 131 31 108 88 99 7.7 23.6 0 361
2 0 0 0 0 0 1 999 999 179 108 116 115 0 0 0 0 0 0 0.7 3.5 178 173 35 113 1.1 10.7 0 207
0 0 0 0 0 1 999 999 165 93 110 116 1 0 0 0 0 0 206 91 47 142 93 105 2.9 0 339
0 0 0 0 0 0 999 999 150 46 82 86 0 0 0 0 0 0 0.6 4 132 77 56 80 107 93 2.5 12.5 0 116
0 0 1 0 0 0 999 999 178 999 88 100 0 0 0 0 0 0 0.9 107 70 36 80 90 79 0
0 0 0 0 0 0 999 999 183 101 106 107 1 0 0 0 0 0 1 3.5 163 149 38 103 116 151 4.2 0 644
0 0 0 0 1 0 999 999 147 46 84 85 0 0 0 0 0 0 0.5 3.4 39.1 0 457
0 0 0 0 0 0 999 999 172 81 109 101 1 0 0 0 0 0 1.3 3.3 123 84 29 80 85 0
2 0 0 0 0 0 1 999 999 165 68 92 95 0 0 0 0 0 0 1.3 9 999 999 999 999 100 96 999 99 0 999
0 0 0 0 0 0 999 999 175 71 0 0 0 0 0 0 0.8 4.1 119 57 51 80 90 90 1.6 26.6 0 172
0 0 0 0 0 0 999 999 161 67 103 97 0 0 0 0 0 0 0.7 4.1 206 115 36 142 118 135 2.6 0
0 0 0 0 0 0 999 999 161 75 101 98 0 0 0 0 0 0 0.9 4.3 196 149 30 137 84 131 2.3 0
0 0 0 0 0 0 999 999 150 57 89 97 1 0 0 0 0 0 0.8 185 112 50 118 101 121 7.2 0 297
0 0 0 0 0 0 999 999 182 106 109 124 1 0 0 0 0 0 0.9 4.3 178 87 39 120 97 82 2.2 0 556
2 0 0 0 0 0 0 999 999 166 69 87 98 0 0 0 0 0 0 0.8 3.9 232 189 53 162 79 75 1.2 0 424
0 0 0 0 0 0 999 999 150 51 78 97 0 0 0 0 0 0 0.7 3.9 205 156 40 142 97 121 1.5 0
0 0 1 0 0 1 130 96 182 117 123 119 1 0 0 0 0 0 0.8 4.1 186 217 28 129 104 109 4 19.3 0 266
0 0 1 0 0 0 999 999 171 82 104 108 0 0 0 0 0 0 0.6 4.2 172 138 40 113 94 82 1.5 0 484
0 0 0 0 0 1 999 999 155 132 141 147 1 0 0 0 0 0 0.8 253 211 64 170 128 133 0.7 0.5 0
0 0 0 0 0 0 999 999 150 73 108 140 1 0 0 1 0 0 0.5 3.8 196 413 30 115 141 263 3.8 10.9 0
0 0 1 0 0 0 999 999 164 68 90 100 0 0 0 0 0 0 0.7 130 120 34 84 147 279 1.4 17.4 0 427
0 0 0 0 0 0 999 999 162 60 999 999 0 0 0 0 0 0 0.7 4 173 175 32 117 97 0.5 0 544
0 0 0 0 0 0 999 999 181 85 999 999 0 0 0 0 0 0 0.7 4.5 184 52 82 86 2.6 0
0 0 0 0 0 0 110 80 153 65 94 106 0 0 0 0 0 0 0.7 4.1 198 236 37 135 98 129 2.4 12.6 0
2 0 0 0 0 0 0 999 999 999 999 91 102 0 0 0 0 0 0 0.7 184 175 42 120 86 134 0
0 0 0 0 0 0 130 80 152 51 73 91 0 0 0 0 0 0 0.8 2.9 213 121 74 125 91 93 0 418
0 0 0 0 0 0 999 999 160 999 93 101 0 0 0 0 0 0 0.6 4.1 94 110 3.5 0 111
0 0 0 0 0 0 999 999 172 72 97 100 0 0 0 0 0 0 0.8 4.7 143 163 24 96 92 154 5.8 18.8 0 329
ecg renaldechosecomets stress red fish fruit fat fast softsweeat sav addlbm slm bf pbf vfa hba ace ccb bb di
0 0 0 0 14 1 2 1 1 1 1 3 7 7 1 40 37 24 37 107 5.7 0 0 0 0
1 0 0 0 31 1 5 5 1 1 1 4 6 4 1 48 45 18.5 27 128 0 0 0 0
0 0 0 0 99 1 6 6 4 4 2 1 1 1 1 51 47 16.9 25 107 0 0 0 0
0 0 0 0 1 1 6 1 1 7 1 1 7 1 45 41 27.2 37 108 0 0 0 0
1 0 0 0 12 1 4 7 2 4 2 3 1 5 1 55 51 16.8 23 99 7.7 0 0 0 0
1 0 0 0 565 4 1 5 6 1 3 1 3 1 4 1 51 48 10 13 50 0 0 0 0
0 0 0 0 5079 32 1 4 6 1 4 2 2 1 3 0 46 43 10.5 19 65 0 0 0 0
0 0 0 0 396 24 1 4 7 2 4 1 2 1 5 1 53 58 24.4 31 124 0 0 0 0
0 0 0 0 3864 13 1 4 6 2 4 2 4 1 5 1 54 50 15 22 72 0 0 0 0
0 0 0 0 532 32 1 5 7 2 4 2 3 1 4 1 25 54 19.5 25 80 0 0 0 0
0 0 0 0 0 37 34 11 23 50 0 0 0 0
0 0 0 0 30 0 58 53 29 33 147 5.5 0 0 0 0
0 0 0 0 0 7.3 0 0 0 0
1 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0
0 0 0 0 3198 22 2 4 7 3 1 2 4 1 2 1 44 40 28.5 40 125 0 0 0 0
0 0 0 0 4095 21 2 2 7 4 4 2 3 1 3 1 65 59 24.2 27 123 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 17 0 0 0 0 0
0 0 0 0 18 0 42 39 17 28 50 0 0 0 0
1 0 0 0 16 3 4 7 3 3 2 2 1 4 1 52 48 17.9 25 85 0 0 0 0
0 0 0 0 35 0 68 63 14 17 58 0 0 0 0
0 0 0 0 12 0 48 44 20.2 30 142 0 0 0 0
0 0 0 0 1522 10 2 5 6 3 6 3 6 6 5 1 76 70 20.4 21 70 0 0 0 0
0 0 0 0 25 2 4 5 2 4 1 1 3 4 1 42 38 23.9 36 99 0 0 0 0
1 0 0 0 5 1 3 5 2 4 3 2 3 5 1 52 48 11.9 18 64 0 0 0 0
0 0 0 0 8 1 3 7 2 1 3 3 1 4 1 39 36 22.6 36 100 0 0 0 0
0 0 0 0 22 0 40 37 13.7 25 50 0 0 0 0
0 0 0 0 13 0 0 0 0 0
0 0 0 0 1194 16 2 5 3 4 2 3 4 1 6 1 58 53 16 22 96 8.5 0 0 0 0
0 0 0 0 456 20 1 5 3 5 7 2 3 1 6 1 44 40 17.7 29 50 0 0 0 0
0 0 0 0 1848 21 0 53 49 10 15 51 0 0 0 0
0 0 0 0 891 8 1 4 6 2 4 2 3 1 4 1 56 52 24.7 30 151 0 0 0 0
1 0 0 0 504 17 1 2 7 2 4 2 4 1 5 1 55 51 18 25 110 0 0 0 0
1 0 0 0 462 20 1 5 6 2 3 1 2 1 4 1 48 45 10 15 52 0 0 0 0
0 0 0 0 13 0 47 43 23 32 72 0 0 0 0
1 0 0 0 12 1 1 6 1 2 2 3 1 4 1 52 48 31 37 191 0 0 0 0
0 0 0 0 1807 16 0 0 0 0 0
0 0 0 0 99 0 45 41 26 37 104 0 0 0 0
0 0 0 0 553 26 1 3 5 6 7 4 7 5 1 1 59 55 18.9 24 73 0 0 0 0
0 0 0 1 99 4 4 6 1 4 1 1 1 3 0 38 35 10 17 50 0 0 0 0
1 0 0 1 7000 21 6 6 3 6 1 2 7 1 6 0 48 45 10 10 50 4 0 0 0 0
1 0 0 1 720 25 0 55 51 10 16 75 5.3 0 0 0 0
0 0 0 0 14 2 5 7 7 4 1 2 1 4 1 64 59 23.5 27 121 0 0 0 0
0 0 0 0 1350 99 6 5 6 2 4 2 1 1 4 1 57 53 18.6 24 103 5.3 0 0 0 0
0 0 0 0 2031 6 1 1 7 2 4 1 3 1 5 1 36 33 16 30 60 5.6 0 0 0 0
0 0 0 0 20 0 61 57 21.6 26 89 0 0 0 0
1 0 1 1 2289 15 2 4 7 3 4 1 3 1 4 1 44 41 10 18 64 0 0 0 0
0 0 0 0 1278 15 1 4 5 4 5 2 4 1 5 1 38 35 23.8 38 113 0 0 0 0
1 0 0 0 2022 25 1 5 7 3 3 1 2 1 4 1 43 39 27.4 38 123 7.9 0 0 0 0
0 0 0 0 1557 99 1 4 5 1 4 1 3 1 2 1 54 49 33.7 38 114 7.5 0 0 0 0
0 0 0 0 2376 27 1 4 7 2 5 2 3 1 4 1 58 53 23 28 109 0 0 0 0
0 0 0 0 3078 99 1 4 5 1 4 4 3 1 5 1 35 32 17 33 71 7.3 0 0 0 0
0 0 0 0 1269 9 1 3 5 1 4 1 3 1 4 1 62 57 24.8 28 133 0 0 0 0
0 0 0 0 19 1 4 5 1 4 1 3 1 5 1 61 56 20 24 104 0 0 0 0
0 0 0 0 35 1 4 5 1 4 2 2 1 1 1 36 33 20.1 36 95 0 0 0 0
1 0 0 0 1105 18 2 3 7 2 4 1 3 1 4 1 36 33 16.2 30 60 0 0 0 0
0 0 0 0 560 21 2 4 5 5 4 1 2 1 4 1 58 54 27.9 32 170 0 0 0 0
0 0 0 0 4980 21 0 74 68 33.6 31 155 0 0 0 0
0 0 0 0 1862 21 1 4 6 4 4 2 1 1 4 1 62 57 31.3 33 182 0 0 0 0
0 0 0 0 4473 19 1 4 6 1 4 2 1 1 1 1 34 32 12.4 26 50 0 0 0 0
0 0 0 0 23 1 4 7 2 4 2 3 1 5 1 55 51 19 25 83 0 0 0 0
1 0 0 0 6481 2 1 3 5 1 4 2 3 1 5 1 76 70 25.3 25 81 0 0 0 0
0 0 0 0 31 0 32 29 14.2 30 54 0 0 0 0
1 0 0 0 693 8 1 3 7 2 2 1 3 1 3 1 58 53 23.1 28 131 0 0 0 0
0 0 0 0 1387 19 2 5 7 3 4 1 3 1 4 1 49 45 17.3 26 116 0 0 0 0
0 0 0 0 534 27 1 4 5 2 4 2 3 1 4 1 58 53 14 20 65 0 0 0 0
0 0 0 0 3042 99 1 2 7 2 3 2 3 1 4 1 46 42 20 31 62 0 0 0 0
0 0 0 0 1557 5 2 4 6 6 4 3 3 1 4 0 51 47 24.2 32 180 0 0 0 0
0 0 0 0 462 15 1 3 7 2 3 1 2 1 4 0 42 39 14.9 26 115 0 0 0 0
1 0 0 0 18 1 3 7 4 4 1 3 1 4 1 75 69 34.1 31 157 0 0 0 0
1 0 0 0 23 1 2 7 4 2 2 3 1 4 1 51 47 18 26 114 0 0 0 0
0 0 0 0 108 18 2 5 7 2 4 1 4 1 4 1 34 31 17.4 33 81 0 0 0 0
1 0 0 0 495 26 1 4 3 4 4 2 4 1 1 0 77 71 39.9 34 153 0 0 0 0
1 0 0 0 3392 15 1 1 7 6 4 4 6 1 6 1 56 52 22.7 28 100 0 0 0 0
1 0 0 1 0 62 56 66 51 200 0 0 0 0
1 0 0 0 2314 20 2 2 7 4 4 1 3 1 2 1 43 39 29.8 41 142 0 0 0 0
0 0 0 0 3015 10 2 5 3 2 3 1 3 1 4 1 51 47 19 27 123 0 0 0 0
1 0 0 0 2197 13 2 4 7 2 1 3 2 1 2 0 49 45 12 19 65 0 0 0 0
0 0 0 0 11 0 63 58 22 26 113 0 0 0 0
0 0 0 0 24 2 4 7 3 4 3 3 1 5 1 42 38 22.8 35 92 0 0 0 0
0 0 0 0 11 0 0 0 0 0
0 0 0 1 7000 15 0 38 35 13.8 26 50 0 0 0 0
0 0 0 0 1738 32 3 3 6 3 7 1 1 1 7 1 45 41 24.5 35 93 0 0 0 0
1 0 0 0 26 0 57 53 17.5 23 75 0 0 0 0
